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ABSTRACT 
Oster, Scott M. Ph.D., Purdue University, May, 2012.  Chronic Ethanol Drinking 
by Alcohol-Preferring Rats Increases the Sensitivity of the Mesolimbic Dopamine 
System to the Reinforcing and Stimulating Effects of Cocaine.  Major Professor: 
James M. Murphy. 
 
 
 
Alcohol and cocaine are commonly co-abused drugs, and those meeting 
criteria for both cocaine and alcohol use disorders experience more severe 
behavioral and health consequences than those with a single disorder. Chronic 
alcohol (ethanol) drinking increased the reinforcing and dopamine (DA) neuronal 
stimulating effects of ethanol within mesolimbic regions of the central nervous 
system (CNS) of alcohol-preferring (P) rats. The objectives of the current study 
were to determine if chronic continuous ethanol drinking produced: (1) alterations 
in the sensitivity of the nucleus accumbens shell (AcbSh) to the reinforcing 
effects of cocaine, (2) changes in the magnitude and time course of the local 
stimulating effects of cocaine on posterior ventral tegmental area (pVTA) DA 
neurons, and (3) a persistence of alterations in the stimulating effects of cocaine 
after a period of protracted abstinence. 
Female P rats received continuous, free-choice access to water and 15% 
v/v ethanol for at least 10 wk (continuous ethanol-drinking; CE) or access to 
water alone (ethanol-naïve; N). A third group of rats received the same period of 
ethanol access followed by 30 d of protracted abstinence from ethanol (ethanol-
abstinent; Ab). CE and Ab rats consumed, on average, 6-7 g/kg/d of ethanol. 
Animals with a single cannula aimed at the AcbSh responded for injections of 
cocaine into the AcbSh during four initial operant sessions. Cocaine was not 
present in the self-infused solution for the subsequent three sessions, and 
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cocaine access was restored during one final session. Animals with dual 
ipsilateral cannulae aimed at the AcbSh and the pVTA were injected with pulsed 
microinfusions of cocaine into the pVTA while DA content was collected for 
analysis through a microdialysis probe inserted into the AcbSh. 
During the initial four sessions, neither CE nor N rats self-infused artificial 
cerebrospinal fluid (aCSF) or 0.1 mM cocaine into the AcbSh. CE, but not N, rats 
self-administered 0.5 mM cocaine into the AcbSh, whereas both groups self-
infused concentrations of 1.0, 2.0, 4.0, or 8.0 mM cocaine. When cocaine access 
was restored in Session 8, CE rats responded more on the active lever and 
obtained more infusions of 0.5, 1.0, 2.0, or 4.0 mM cocaine compared to N rats. 
Microinjection of aCSF into the pVTA did not alter AcbSh DA levels in N, CE, or 
Ab rats. Microinjections of 0.25 mM cocaine into the pVTA did not significantly 
alter AcbSh DA levels in N animals, moderately increased DA levels in CE rats, 
and greatly increased DA levels in Ab rats. Microinjections of 0.5 mM cocaine 
into the pVTA modestly increased AcbSh DA levels in N animals, robustly 
increased DA levels in CE rats, and did not significantly alter DA levels in Ab rats. 
Microinjections of 1.0 or 2.0 mM cocaine into the pVTA modestly increased 
AcbSh DA levels in N animals but decreased DA levels in CE and Ab rats. 
Overall, long-term continuous ethanol drinking by P rats enhanced both 
the reinforcing effects of cocaine within the AcbSh and the stimulatory and 
inhibitory effects of cocaine on pVTA DA neurons. Alterations in the stimulatory 
and inhibitory effects of cocaine on pVTA DA neurons were not only enduring, 
but also enhanced, following a period of protracted abstinence from ethanol 
exposure. Translationally, prevention of chronic and excessive alcohol intake in 
populations with a genetic risk for substance abuse may reduce the likelihood of 
subsequent cocaine use. 
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1. INTRODUCTION 
 Addiction and Polydrug Use 
 
A definitive feature of substance abuse is an individual’s transition from a 
controlled use of drugs or alcohol to a state where compulsive substance use 
involves a ‘loss of control’ (DSM-IV, American Psychiatric Association, 1994). 
Along these lines, addiction is generally expressed as maladaptive changes in 
spontaneous behavior and the behavioral response to a drug after continued 
use, resulting from drug-induced adaptations in the central nervous system 
(CNS; Kalivas, 2009). More than 50% of Americans over the age of 12 (120 
million) are current alcohol users, and nearly 8% of those (18 million) met criteria 
for substance abuse or dependence (Substance Abuse and Mental Health 
Services Administration, 2008). Moreover, nearly 16% of adults in the United 
States (29 million) will participate in non-medical or illicit drug use in their lifetime, 
with 3% (5.4 million) meeting criteria for drug dependence at some point (Grant 
and Dawson, 1998; Grant et al., 2004). Of this illicit drug use, cocaine continues 
to be a significant problem. In 2005, 2.4 million and 1.5 million Americans were 
classified as users and abusers, respectively (Substance Abuse and Mental 
Health Services Administration, 2005). Cocaine use accounted for 29% of all 
drug-related emergency department visits in 2000, more than any other illicit 
drug. Substance abuse and dependence were associated with an increased risk 
of physical and mental illness, disability, lost work productivity, financial 
problems, committing and suffering violence, accidents, and death (Rehm et al., 
2006). Estimates predict that 23% of alcohol users and 21% of cocaine users will 
become dependent at some time in their life (Lopez-Quintero et al., 2011b).  
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Those with a diagnosis of an alcohol use disorder (abuse or dependence) 
were seven times more likely to develop another drug use disorder as those 
without a diagnosis of alcohol abuse or dependence (Compton et al., 2007). 
Subjects with the diagnosis of alcohol dependence were more likely to become 
cocaine misusers and experience more adverse consequences of cocaine use, 
and alcohol abuse was a common problem among cocaine dependent patients 
(Heil et al., 2001; Staines et al., 2001). Those with a previous diagnosis of 
cocaine dependence were less likely to remit from alcohol dependence (Lopez-
Quintero et al., 2011a). Moreover, a significant proportion of those seeking 
treatment for either alcohol or cocaine abuse concurrently used both drugs. For 
example, the majority of cocaine users reported co-administering alcohol during 
cocaine binges (Brookoff et al., 1996; Carroll et al., 1993; Grant and Harford, 
1990; Magura and Rosenblum, 2000). Estimates suggest that 20-63% of alcohol-
dependent patients qualified as cocaine-dependent (Miller and Giannini, 1991), 
while 62-85% of cocaine-dependent individuals were dependent on alcohol 
(Regier et al., 1990; Rounsaville et al., 1991). Individuals with comorbid drug and 
alcohol use disorders met a higher number of criteria for each disorder, and thus 
displayed more severe dependence-related problems than those with a single 
disorder. Those who co-abused alcohol and other drugs were also more likely to 
be diagnosed with psychiatric disorders, attempt suicide, and suffer health 
problems (Arnaout and Petrakis, 2008). Patients who were both cocaine- and 
alcohol-dependent displayed more psychosocial problems compared to patients 
with only alcohol dependence or cocaine dependence (Brady et al., 1995; Carroll 
et al., 1993; Walsh et al., 1991). Furthermore, chronic abuse of either cocaine or 
alcohol left multiple metabolic and structural brain defects after protracted 
abstinence, and concomitant dependence on both substances aggravated white-
matter structural defects in frontal cortical brain regions (O’Neill et al., 2001).  
In studies of drug use initiation order, alcohol and tobacco are most 
commonly used first, followed by marijuana, and finally other illicit drugs 
(Ellickson et al., 1992; Fergusson et al., 2006). Kandel and Faust (1975) initially 
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proposed this sequence as the ‘gateway’ hypothesis, suggesting use at each 
stage increases the number of users progressing to the next stage. While 
longitudinal studies support a causal effect of alcohol and tobacco use on 
subsequent illicit drug use (Van Gundy and Rebellon, 2006), one must account 
for the potential existence of one or more unmeasured common causes (Morral 
et al., 2002). Accordingly, background prevalence at least partially affected 
substance use progression patterns when patterns from multiple countries 
around the world were analyzed (Degenhardt et al., 2010). Interestingly, the 
initiation of alcohol and tobacco use was more significantly associated with the 
subsequent onset of illicit drug use in countries with higher rates of 
alcohol/tobacco use (e.g. the United States) compared to countries with lower 
use rates (e.g. Nigeria and South Africa). While early onset drug use often 
predicted an increased risk of transition to dependence (Behrendt et al., 2009; 
Dawson et al., 2008; Grant et al., 2001), the risk of transitioning to dependence 
may depend as much upon the existence of a concurrent psychiatric or other 
substance use disorder (Behrendt et al., 2009; Degenhardt et al., 2009; Lopez-
Quintero et al., 2011b). Associative learning processes, rapid neuroadaptations, 
and drug interactions potentially mediated the enhanced speed of transition from 
cocaine use to dependence resulting from a previous history of a distinct 
substance use disorder, via enhanced drug effects and/or decreased adverse 
effects (Bradberry et al., 1999; Kapusta et al., 2007; Leri et al., 2003; Schlaepfer 
et al., 2008).  
Genetic factors played a significant role in the pattern of comorbidity of 
common psychiatric and substance use disorders when examined in family, twin, 
and genome-wide studies (Burmeister et al., 2008; Kendler et al., 2003; Li and 
Burmeister, 2009). Dependence on multiple substances had a high genetic 
liability, and polysubstance abuse was associated with a number of alleles on 
several genes (Agrawal et al., 2008; Schlaepfer et al., 2008). Moreover, while 
both genetic and environmental factors played a role in twin concordance of 
cocaine use, genetic factors more significantly impacted the concordance of 
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abuse and dependence (Kendler and Prescott, 1998; Kendler et al., 2000). For 
example, 59% of those diagnosed with an alcohol use disorder and 77% of those 
diagnosed with a cocaine use disorder had family histories with substance use 
disorders (Lopez-Quintero et al., 2011b). Furthermore, the rate of cocaine-
dependence was nearly three times higher in individuals with a genetic 
predisposition for alcoholism compared to the general population (Nurnberger et 
al., 2004). The initiation of alcohol use predicts the subsequent use of illicit drugs, 
but questions regarding causality remain when examining epidemiological data. 
Experiments using animal models of drug use can be used to examine the 
sequence of drug initiation and elucidate putative neurobiological substrates for 
adaptive processes contributing to the observed changes in behavior. 
 The Role of Mesocorticolimbic Dopamine 
 
Compulsive and maladaptive drug-taking and drug-seeking behaviors are 
associated with neuroplastic changes within the mesocorticolimbic dopamine 
(DA) pathway and its afferent and efferent connections (Everitt and Robbins, 
2005; Koob and Volkow, 2010; Nestler, 2005; Wise, 2004). The 
mesocorticolimbic (MCL) system consists of DA cell bodies in the ventral 
tegmental area (VTA), sending efferent projections to a number of cortical and 
basal ‘limbic’ forebrain structures, including the nucleus accumbens (Acb), 
ventral pallidum (VP), amygdala, olfactory tubercle (OT), septum, bed nucleus of 
the stria terminalis (BNST), hypothalamus, thalamus, habenula, hippocampus, 
prefrontal cortex (PFC), orbitofrontal cortex, and anterior cingulate (Hasue and 
Shammah-Lagnado, 2002; Nauta et al., 1978; Oades and Halliday, 1987; 
Phillipson, 1979a; Sesack and Grace; 2010; Swanson, 1982). VTA DA neurons 
were implicated in a number of functions, including: the facilitation of approach 
behaviors; the mediation of positive reinforcement; error prediction of 
reinforcement; and the mediation of associative learning processes, such as 
selection, initiation, and invigoration of learned behaviors (Baldo and Kelley, 
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2007; Fields et al., 2007; Grace et al., 2007; Horvitz, 2000; Ikemoto, 2007; Kelley 
and Berridge, 2002; Redgrave et al., 2008; Robbins and Everitt, 1996; Salamone 
et al., 2003; Schultz, 2007; Wise, 2004). While these functions are conceptually 
distinct, they are difficult to separate experimentally (Fields et al., 2007; Ikemoto 
and Panksepp, 1999). Moreover, firing patterns of VTA DA neurons and both 
increases and decreases in terminal DA levels were associated with stress, 
novelty, negative reinforcement, and aversive/noxious stimuli (Brischoux et al., 
2009; Carlezon and Thomas, 2009; Liu et al., 2008; Ungless et al., 2010).  
The MCL system facilitates complex hierarchical control of adaptive 
ingestive behavior by integrating temporally and spatially coincident events into 
associations, allowing for adaptive and goal-directed behaviors and ultimately, 
survival (Kelley, 2004). Briefly, the constructs of ‘reward’ and ‘reinforcement’ are 
related, but distinct. Reward can be conceptualized as an unconditioned stimulus 
eliciting an appetitive approach response from an organism (Fields et al., 2007; 
Ikemoto and Panksepp, 1999; Young, 1959), distinct from the concept of reward 
as a positive hedonic experience (i.e. euphoria or liking). Reinforcement refers to 
the strengthening of associations between an action, a stimulus contingent to an 
outcome, and an outcome contingent to an action (Skinner, 1938). A number of 
novel stimuli initially unpaired with behavioral outcomes but possessing salience 
due to high intensity and abrupt onset affected the activity of VTA DA neurons 
(Schultz et al., 1998). Unexpected natural rewards and conditioned cues 
predicting reinforcement, both motivationally relevant events, induced firing of 
VTA DA neurons (McClure et al., 2003; Phillips et al., 2003). Thus, DA release in 
terminal areas, such as the Acb, was potentially involved with the response to the 
delivery of a reinforcer and enabled motivated actions toward future 
reinforcement (Wise, 2004). As such, MCL DA potentially functions primarily to 
guide instrumental behavior and is less associated with the consummatory act 
(Robinson and Berridge, 1993; Salamone et al., 2003). Theoretically, DA 
released in terminal areas acts: to alert the organism to the appearance of a 
novel salient stimuli and promote learning through neuroplasticity, and to alert the 
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organism of a future presentation of a familiar motivationally relevant event 
based on learned associations with stimuli predicting the event (Keitz et al., 
2003; McClure et al., 2003). Interestingly, different subsets of neurons within the 
Acb may respond preferentially to different motivationally relevant stimuli, such 
as water versus cocaine (Carelli and Wondolowski, 2003).  
On the other hand, a number of similarities between drug and non-drug 
(e.g. food, sex, exercise, gambling) reinforcers exist with regards to both 
behavioral and neurobiological responses (Corwin and Hajnal, 2005; Levine et 
al., 2003; Pelchat et al., 2004; Potenza, 2008; Volkow and Wise, 2005). For 
example, acute exposure either drugs of abuse (e.g. ethanol, cocaine, nicotine) 
or sucrose resulted in increased DA levels within terminal regions of the MCL 
system (Carr, 2002; Di Chiara and Imperato, 1988; Hajnal et al., 2004; Rada et 
al., 2005). Furthermore, hunger was not required to produce food or sucrose 
craving (Grimm et al., 2007; Pelchat et al., 2004), just as withdrawal is not 
necessary for drug craving (Shaham et al., 2003). Interactive effects between 
drug and non-drug reinforcement processes potentially resulted from common 
neural substrates. For example, the process of oral ethanol consumption 
activated reinforcement circuitry through both direct mechanisms and indirectly 
via the stimulation of neural substrates associated with the taste of sugar (Lemon 
et al., 2004). In addition, excessive seeking and consumption of food and 
sucrose followed a similar progression of compulsive and maladaptive behaviors 
associated with drug addiction (Ahmed, 2005; Avena et al., 2008; Carr, 2007; 
Koob and Volkow, 2010; Wise, 2004). Sucrose and drug reinforcers displayed 
both cross-sensitization (Avena and Hoebel, 2003a,b; Colantuoni et al., 2001; 
Gosnell, 2005) and cross-tolerance (D’Anci et al., 1996). Moreover, sequential 
exposure to drug and non-drug reinforcers produced interactive effects with 
regard to intake escalation (Avena et al., 2008; Colantuoni et al., 2002), 
withdrawal effects (Colantuoni et al., 2002), and relapse (Shalev et al., 2006). 
Drugs of abuse produced a functional reorganization of the MCL system in 
the form of robust and persistent neuronal plasticity, leading to the formation of 
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maladaptive behaviors and ultimately compulsive drug seeking (Kalivas and 
Volkow, 2005; Self and Nestler, 1998; Steketee and Kalivas, 2011; Wolf et al., 
2004; Zweifel et al., 2008). While drugs of abuse induced functional alterations 
throughout the MCL and its afferent and efferent connections, the 
mesoaccumbens division of the MCL is of particular interest in the initiation and 
early formation of maladaptive neuroplasticity. The mesoaccumbens (or meso-
ventrostriatal) circuit can be divided into two functionally distinct, but interrelated 
systems (Ikemoto, 2007). These systems are: the meso-ventromedial (MVM) 
circuit from the caudomedial (posterior) VTA (pVTA) to the medial Acb shell 
(AcbSh) and medial OT, and the meso-ventrolateral (MVL) circuit from the 
rostrolateral (anterior) VTA (aVTA) to the lateral AcbSh, Acb core (AcbC), and 
lateral OT. For future reference, AcbSh will refer to the medial AcbSh, as nearly 
all experiments evaluating the function of the AcbSh have specifically targeted 
medial regions. Research into the mechanisms of drugs of abuse within the MVM 
is of particular interest, as both the pVTA and AcbSh are critical substrates for 
the acute reinforcing effects of drugs and for the initiation of associative learning 
(Gonzales et al., 2004; Ikemoto, 2007; Ikemoto and Panksepp, 1999; Kelley, 
2004; Koob and Volkow, 2010; Koob et al., 1998; McBride et al., 1999; Nestler, 
2005; Wise, 2004). The dynamic role of MVM dopaminergic functioning in 
reinforcement and learning processes has frequently been assessed using a 
number of well established behavioral and neurochemical assays. 
 
 Behavioral and Neurobiological Assays 
 
In vivo microdialysis, voltammetry, and electrophysiological measurement 
(for review, see Marinelli et al., 2006; Salamone et al., 1996, Torregrossa and 
Kalivas, 2008), as well as intracranial self-administration (ICSA) and intracranial 
place conditioning (for review, see Ikemoto, 2007, 2010; McBride et al., 1999; 
Sanchis-Segura and Spanagel, 2006; Tzschentke, 1998, 2007; Wise and 
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Hoffman, 1992), are examples of assays implemented in the characterization of 
specific brain sites involved in reinforcement and learning processes. The 
investigation of the neurocircuitry and mechanisms associated with drug 
reinforcement using both neurochemical (e.g. in vivo microdialysis) and 
behavioral (e.g. ICSA) techniques provide convergent evidence associating 
functional alterations in neurotransmitter output with changes in behavioral output 
(Torregrossa and Kalivas, 2008). 
The ICSA technique is a valuable method for the identification and 
classification of discrete brain regions responsible for the initiation and 
maintenance of response-contingent delivery of a chemical reinforcer (Goeders 
and Smith, 1987). ICSA procedures have reliably identified brain sites involved in 
mediating the reinforcing effects of drugs of abuse and have examined brain 
sites, neuronal pathways, and receptor systems involved in mediating operant 
reinforcement behavior (for review, see Goeders and Smith, 1987; Ikemoto, 
2007, 2010; Wise, 2002; McBride et al., 1999). In some cases, a chemical 
agent's neural ‘trigger-zone’ contains cell bodies, whereas in other cases it is 
within a terminal region. Drugs of abuse can act within the brain in a reinforcing 
manner by mimicking, enhancing, or blocking the actions of endogenous 
transmitters in the brain within particular anatomical substrates of the MCL DA 
system (Wise and Hoffman, 1992) and sites sending afferent innervation to MCL 
sites (Ikemoto, 2010). Using the ICSA paradigm, animals receive the delivery of 
nanoliter volumes of a drug solution into a discrete brain region a response-
contingent manner. The ICSA procedure has been used to elucidate specific 
central nervous system sites, neuronal systems, and receptor types involved in 
reinforcement and the interactions between these systems (McBride et al., 1999). 
By using intracranial drug delivery, the ICSA technique presents fewer 
anatomical and pharmacological limitations compared to the intracranial electrical 
self-stimulation and intravenous self-administration (IVSA) methods. 
The microinjection-microdialysis procedure has identified specific brain 
sites involved in the actions of drugs and other pharmacological agents and the 
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corresponding neurotransmitter responses in associated brain sites (Ding et al., 
2009a,b; Guan and McBride, 1989; Ikemoto et al., 1997b). For example, 
microinjection-microdialysis techniques have explored the specific ‘downstream 
response’ of ICSA-like pulsed drug microinfusions to the pVTA (which contain 
MVM DA neurons) on extracellular DA levels in terminal regions such as the 
AcbSh. Drug administration is contingent upon operant responding in the ICSA 
paradigm, but not during microinjection-microdialysis. Along these lines, certain 
neurobiological assays captured the effects of drug contingency on the 
expression of functional alterations to the MCL system (Chen et al., 2008), while 
other assays did not find significant effects of contingency (Geisler et al., 2008).  
The microinjection-microdialysis paradigm examines the initial (non-
contingent) pharmacological effects presumably observed during the initiation of 
response-contingent behaviors in parallel ICSA experiments. Nevertheless, 
changes in Acb DA levels are extremely similar after either operant oral ethanol 
consumption (Melendez et al., 2002; Weiss et al., 1996) or pVTA microinjection 
of ethanol (Ding et al., 2009a). Moreover, microinjections of the ethanol 
metabolites acetaldehyde or salsolinol, or cocaine into the pVTA, but not the 
aVTA, increased extracellular DA levels within the Acb (current results; Deehan 
et al., 2007; Rodd et al., 2006b). Accordingly, rats will self-administer these 
reinforcing compounds (cocaine, ethanol, acetaldehyde, salsolinol) into the 
pVTA, but not aVTA (Rodd et al., 2004a,b, 2005a,b,c,d, 2008; Rodd-Henricks et 
al., 2000a, 2002b, 2003). Of note, in vivo microdialysis is a measurement tool 
best utilized to assess ‘tonic’, opposed to ‘phasic’, dopaminergic functioning 
(Grace, 2000; Grace et al., 2007). In this regard, observed changes in 
extracellular DA were correlated with the number of spontaneously active VTA 
DA neurons, but not with the average firing frequency or burst activity of VTA DA 
neurons (Floresco et al., 2003; Marinelli et al., 2006). 
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 Mesoaccumbens Circuit: Connectivity and Heterogeneity 
 Ventral Tegmental Area: Connectivity 
 
The VTA consists of a number of adjacent heterogeneous groups of cells 
positioned medially and ventrally within the midbrain (Tsai, 1925a,b; Dahlstrom 
and Fuxe, 1964). The VTA contains the majority of what is historically known as 
the A10 DA cell bodies, although there is no clear boundary between A9 nigral 
and A10 tegmental neurons (Dahlstrom and Fuxe, 1964; Lindvall and Bjorklund, 
1978; Oades and Halliday, 1987). The VTA contains mostly DA neurons (around 
65%; Swanson, 1982; Nair-Roberts et al., 2008), with gamma-aminobutyric acid 
(GABA; Swanson, 1982; Steffensen et al., 1998) and glutamate (Nair-Roberts et 
al., 2008) neurons present to a lesser degree (around 30-35% and 3%, 
respectively). These DA neurons send significant projections to limbic and 
cortical areas, while less prominently innervating striatal, diencephalic, and 
rhombencephalic areas (Oades and Halliday, 1987).  
The VTA receives abundant afferent projections, forming a continuous 
band of neurons not organized into discrete nuclei, from a number of regions 
(predominantly ‘limbic’ structures) including the: PFC, lateral septum, medial 
septum-diagonal band complex, Acb, VP, BNST, amygdala, medial and lateral 
preoptic area, lateral hypothalamus, lateral habenula, dorsal raphe, rostromedial 
tegmental nucleus, pedunculopontine tegmental nucleus, laterodorsal 
tegmentum, periaqueductal gray, and mesencephalic and pontine reticular 
formation (Carter and Fibiger, 1977; Dahlstrom and Fuxe, 1964; Geisler and 
Zahm, 2005; Lindvall and Bjorklund, 1978; Mena-Segovia et al., 2008; Oades 
and Halliday, 1987; Phillipson, 1979b). These afferent inputs provide excitatory, 
inhibitory, and modulatory innervation to the DA, GABA, and glutamate neurons 
within the VTA via the release of a number of neurotransmitters and 
neuromodulators, including: acetylcholine (ACh), GABA, glutamate, 
norepinephrine, serotonin, endogenous opioids, corticotrophin releasing factor 
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(CRF), and orexin (ORX). The VTA sends efferent projections from DA and 
GABA neurons, with minimal branching and considerable overlap, innervating 
cortical regions (e.g. prefrontal, insular, medial frontal, entorhinal, cingulate, 
anterior suprarhinal), Acb, lateral septum, BNST, amygdala, OT, dorsal 
hippocampus, lateral habenula, thalamus, reticular formation, central gray, locus 
coeruleus, median and dorsal raphe nuclei, and the anteromedial striatum 
(Beckstead et al., 1979; Carter and Fibiger, 1977; Fallon and Moore, 1978; 
Ikemoto, 2007; Nauta et al., 1978; Oades and Halliday, 1987; Swanson, 1982).  
Anatomically, the VTA is a heterogeneous structure composed of five 
identified nuclei: paranigral, parabrachial, interfascicular, rostral linear, and 
caudal linear (for review, see Oades and Halliday, 1987). VTA cytoarchitecture 
includes morphologically distinct dopaminergic cells exhibiting specialized axonal 
projections (Halliday and Tork, 1984; Phillipson, 1979a) and topographic afferent 
and efferent projections (Brog et al., 1993; Fallon and Moore, 1978; Fallon, 1988; 
Hasue and Shammah-Lagnado, 2002; Kalen et al., 1988; Tan et al., 1995). For 
instance, the raphe nuclei send serotonin projections primarily innervating the 
interfascicular and paranigral of the VTA, with less innervation of the dorsorostral 
VTA (Herve et al., 1987). Moreover, reciprocal projections to the dorsal raphe 
nucleus originate almost exclusively from the caudal VTA (Kalen et al., 1988). 
Moreover, the paranigral region contains a greater density of serotonergic 
varicosities and sends projections primarily to the AcbSh, whereas the lateral PB 
region has less serotonergic innervation and projects predominantly to the AcbC 
(Van Bockstaele et al., 1994). While the majority of DA neurons originate from 
within the pVTA, most GABA and glutamate neurons are located in the aVTA 
(German and Manaye, 1993; Ikemoto, 2007; Nair-Roberts et al., 2008; Olson and 
Nestler, 2007; Swanson, 1982; Yamaguchi et al., 2007). ACh neurons 
preferentially innervate mesoaccumbens neurons in the VTA (Omelchenko and 
Sesack, 2006), and activation of nicotinic ACh receptors within the pVTA, but not 
aVTA, activated DA neurons (Zhao-Shea et al., 2011). ORX neurons synapse on 
DA neurons projecting to the PFC and AcbSh, but not the AcbC (Vittoz et al., 
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2008). Medial portions of the parabrachial project to the AcbSh and medial OT, 
while the lateral parabrachial projects to the AcbC, lateral AcbSh, and lateral OT 
(Ikemoto, 2007). 
 Nucleus Accumbens: Connectivity 
 
The Acb is part of the ventral striatal complex (Zahm, 2000; Zahm and 
Brog, 1992) receiving extensive excitatory afferents from the cortex and thalamus 
(Sesack and Grace, 2010). The AcbSh and AcbC share striatal characteristics, 
as approximately 90% of the cells are medium spiny projection GABA neurons 
(MSN; Meredith, 1999). The remaining cells are primarily ACh interneurons, with 
an extensive network of axons and terminals innervating MSNs within both the 
AcbSh and AcbC (Meredith and Chang, 1994; Kawaguchi et al., 1995). The Acb 
receives afferent innervation from the VTA, VP, substantia nigra (SN) pars 
compacta, dorsal raphe, locus coeruleus, periaqueductal gray, pedunculopontine 
tegmental nucleus, lateral hypothalamus, cortex (PFC, limbic, orbital, and 
insular), subiculum of the hippocampus, and amygdala (Kelley et al., 1982; 
Reynolds and Zahm, 2005; Van Bockstaele and Pickel, 1995; Voorn et al., 1986). 
These afferents are excitatory, inhibitory, and modulatory through the release of 
GABA, glutamate, norepinephrine, serotonin, and ORX (Sesack and Grace, 
2010). The Acb sends efferent projections to the hypothalamus, VP, VTA, SN, 
and other brainstem areas (Haber et al., 1990; Heimer et al., 1991; Zahm, 2000). 
The AcbSh and AcbC differ in their afferent and efferent projection patterns, 
neurochemistry, cellular morphology, and overall function (Heimer et al., 1991; 
Meredith et al., 1992, 1996; Brog et al., 1993; Zahm and Heimer, 1993).  
Both dopaminergic and non-dopaminergic innervation of the Acb appears 
to display a similar medial-lateral topography (Ikemoto, 2007; Sesack and Grace, 
2010). For example, ventral portions of the subiculum and limbic and orbital 
cortices innervate the AcbSh, whereas the dorsal aspects of these regions 
project to the AcbC (Brog et al., 1993). In addition, ORX neurons from the 
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hypothalamus innervate the AcbSh, but not the AcbC. DA afferents from the VTA 
to the Acb synapse onto GABA MSNs (Pickel and Chan, 1990; Pickel et al., 
1988). These MSNs also receive excitatory synapses from cortical axon 
terminals often organized in a ‘triad’ arrangement, allowing DA to display 
inhibitory or modulatory synapses (Sesack and Pickel, 1990, 1992). DA axons in 
the Acb do not appear to selectively modulate particular glutamate afferents, but 
potentially act more commonly through volume transmission (Sesack and Grace, 
2010). Supporting this idea are the findings that DA receptors in the Acb are 
primarily extrasynaptic (Sesack, 2009), DA communicates through both synaptic 
and volume transmission (Moss and Bolam, 2008) and modulates the general 
excitability of glutamate neurons (Nicola et al., 2000; Surmeier et al., 2007). 
The AcbSh innervates the ventromedial VP, VTA, SN pars compacta, 
lateral hypothalamus, lateral preoptic area, periaqueductal gray, and 
pedunculopontine tegmental nucleus; while the AcbC innervates the dorsomedial 
VP, SN zona reticulata, and entopeduncular nucleus (Haber et al., 1990; Heimer 
et al., 1991). The dorsolateral VP then sends projections to the SN reticulata and 
subthalamic nucleus, while the ventromedial VP innervates the VTA and basal 
forebrain. This allows for not only an indirect and direct feedback loop from the 
forebrain to the midbrain, but also a spiral loop moving from ventromedial to 
dorsolateral striatal areas (Nauta et al., 1978; Zahm and Heimer, 1993). This 
spiral loop forms a pVTA-AcbSh-aVTA-AcbC-SNreticulata-striatum pattern of 
connectivity allowing ‘limbic’ structures to affect transmission in more motor-
related structures of the basal forebrain (Sesack and Grace, 2010). This 
corresponds to Mogenson’s conceptualization of the Acb as an interface where 
motivations from limbic regions interact with motor circuitry to drive motivated 
behavior (Mogenson et al., 1980). 
Overall, firing of DA neurons in the VTA produces the release of DA from 
terminals in the Acb (Sombers et al., 2009) and from the soma and dendrites 
within the VTA (Beart et al., 1979; Kalivas and Duffy, 1991) in an impulse-
dependent manner (Beckstead et al., 2007; Kita et al., 2009). DA released within 
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the Acb activates DA-receptor-1-like (D1 and D5) and DA-receptor-2-like (D2, D3, 
and D4) receptors. These receptors will be referred to from this point as simply D1 
and D2 unless otherwise noted. Activation of D1 receptors increase adenylyl 
cyclase (AC) activity via stimulatory G-proteins to increase cyclic adenosine 
monophosphate (cAMP) levels, while the D2 receptor is negative coupled to AC 
and cAMP (Lachowicz and Sibley, 1997). While co-localization of presynaptic D1 
and D2 receptors in the Acb is common (Wong et al., 1999), different populations 
of MSNs express either D1 or D2 receptors postsynaptically almost exclusively 
(Le Moine and Bloch, 1996; Lee et al., 2006). However, mixed physiological 
response-patterns to receptor manipulation are often observed due to the co-
expression of the D3 receptors on D1-expressing MSNs in the AcbSh (Le Moine 
and Bloch, 1996; Ridray et al., 1998). Activation of D1 receptors in the Acb 
enhances glutamatergic drive (Chergui and Lacey, 1999; West and Grace, 2002) 
via increased AC activity (Sibley et al., 1993), while activation of D2 receptors 
inhibits Acb neurons via decreased AC activity (White and Wang, 1986; 
O’Donnell and Grace, 1996). MSNs with D2 receptors project almost exclusively 
to the VP, whereas D1-containing MSNs project to both the VP and VTA (Lu et 
al., 1997, 1998). 
 Ventral Tegmental Area: Regional Heterogeneity 
 
In addition to differences in morphology and connectivity, the VTA is also 
functionally heterogeneous with regards to drugs of abuse. Using viral-mediated 
gene transfer, over-expression of glutamate receptor subunit type one (Carlezon 
et al., 2000) or phospholipase C gamma-1 (Bolanos et al., 2003) in the aVTA 
increased morphine place preference, while over-expression in the pVTA 
resulted in morphine place avoidance. Moreover, over-expression of cAMP-
response-element-binding protein (CREB) in the aVTA increased place 
preference for either cocaine or morphine, while over-expression in the pVTA 
resulted in place avoidance for these drugs (Olson et al., 2005). Furthermore, a 
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number of drugs of abuse and receptor ligands are self-administered directly into 
the pVTA, but not the aVTA, using the ICSA paradigm. These drugs include: 
cocaine (Rodd et al., 2005a), nicotine (Ikemoto et al., 2006), ethanol (Rodd et al., 
2004a,b, 2005b,c,d; Rodd-Henricks et al., 2000a, 2003), the ethanol metabolites 
acetaldehyde and salsolinol (Rodd et al., 2005d, 2008; Rodd-Henricks et al., 
2002b), delta-9 tetrahydrocannabinol (THC; Zangen et al., 2006), endomorphin-1 
(Zangen et al., 2002), a serotonin receptor type 3 (5-HT3) agonist (Rodd et al., 
2007), and a muscarinic ACh receptor agonist (Ikemoto and Wise, 2002). 
Moreover, THC, endomorphin-1 and the muscarinic agonist produced a place 
preference when injected into the pVTA, but not aVTA, using an intracranial 
place-conditioning paradigm (Ikemoto and Wise, 2002; Zangen et al., 2002, 
2006). 
 Nucleus Accumbens: Regional Heterogeneity 
 
A number of experiments observed a functional divide in the Acb in 
addition to the observed heterogeneity found in the VTA. Repeated injections of 
amphetamine into the AcbSh, but not AcbC, produced both a behavioral 
sensitization to locomotor stimulation and a neurochemical sensitization to 
increases in DA (Pierce and Kalivas, 1995). Moreover, amphetamine 
sensitization increased presynaptic proteins associated with synaptic plasticity 
and the regulation of DA release in the AcbSh, but reduced protein levels in the 
AcbC (Subramaniam et al., 2001). Similarly, chronic cocaine treatment produced 
a robust and persistent depression in MSN activity in the AcbSh, while MSNs in 
the AcbC were transiently activated (Kourrich and Thomas, 2009). Systemic 
administration of cocaine, morphine, and amphetamine preferentially increase 
extracellular DA in the AcbSh compared with the AcbC (Pontieri et al., 1995). 
The AcbSh was also more responsive than the AcbC to systemic administration 
of D1 receptor agonists and antagonists when measuring ACh output (Consolo et 
al., 1999). Interestingly, injections of N-methyl-D-aspartic acid (NMDA) 
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antagonists into the AcbC, but not the AcbSh, reduced cocaine-induced 
locomotor activity (Pulvirenti et al., 1994).  
Direct stimulation of D1 or D2 receptors within the AcbSh, but not the 
AcbC, produced a cocaine-primed ‘reinstatement of responding’ following 
cocaine IVSA and extinction (Bachtell et al., 2005; Schmidt et al. 2006) blocked 
by co-infusion of the respective receptor antagonist (Schmidt and Pierce, 2006). 
Conversely, D1 or D2 receptor antagonists injected into the AcbSh, but not the 
AcbC, blocked the ‘reinstatement of responding’ (Anderson et al., 2003, 2006; 
Bachtell et al., 2005). In addition, 6-hydroxydopamine lesions to the AcbSh, but 
not the AcbC, attenuated the conditioned place preference (CPP) for cocaine, 
while lesions to the AcbC, but not the AcbSh, reduced cocaine-induced increases 
in locomotor activity (Sellings et al., 2006). Both contingent (Hemby et al., 1997; 
Parsons et al., 1995) and non-contingent (Cadoni and Di Chiara, 1999; Hedou et 
al., 1999; Pontieri et al., 1995) administration of cocaine produced greater 
increases in DA within the AcbSh than the AcbC. Lastly, DA terminals in the 
AcbSh, but not the AcbC, can co-release glutamate (Stuber et al., 2010). 
Utilizing the ICSA method, rats learned to self-administer the following 
agents into the AcbSh, but not the AcbC: cocaine (Katner et al., 2011, Rodd-
Henricks et al., 2002a), ethanol (Engleman et al., 2009), the ethanol metabolite 
salsolinol (Rodd et al., 2003b), amphetamine (Ikemoto et al., 2005), THC 
(Zangen et al., 2002), a DA reuptake inhibitor (Carlezon et al., 1995), a 
combination of D1 and D2 agonists (but neither individually; Ikemoto et al., 
1997a), a muscarinic ACh agonist (Ikemoto et al., 1998), and NMDA antagonists 
(Carlezon and Wise, 1996). Additionally, rats displayed a CPP for injections of 
THC into the AcbSh, but not into the AcbC (Zangen et al., 2002). Overall, 
connections from the pVTA to the AcbSh appear to be important for modulating 
motivational salience and establishing learned associations between motivational 
events and concurrent environmental stimuli, whereas the aVTA-AcbC circuit 
primarily mediates the expression of learned behaviors in response to stimuli 
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predicting motivational relevant events (Bassareo and Di Chiara, 1999; Di Ciano 
and Everitt, 2001; Kelley, 2004; Ikemoto; 2007).  
 Drugs of Abuse Produce Alterations in Mesocorticolimbic Functioning 
 
Compulsive and maladaptive behaviors associated with excessive drug 
taking and drug seeking result from persistent, and possibly, permanent 
alterations in the functioning of the MCL DA system and associated structures 
(Hyman et al., 2006; Kalivas, 2009; Koob and Volkow, 2010; Nestler, 2001; Wise, 
2004). A key feature of addiction is the compromised ability to suppress 
compulsive drug seeking, even when faced with serious adverse consequences 
(Kalivas, 2009; Kalivas and Volkow, 2005). A susceptibility to relapse can remain 
for years after abstinence from drug use, and underscores the contributions of 
repeated drug exposure, genetic background, and associations between 
environmental stimuli and drug use (learning). During the initial experiences with 
drugs of abuse, the acute pharmacological drug effects and the relevant 
associative learning processes concomitantly activate the same neural circuitry 
(e.g. MVM DA: neuronal firing in the pVTA and increased DA release in the 
AcbSh). With continued drug use, the dopaminergic response within the AcbSh 
became sensitized to the acute drug effects (Hooks et al., 1994; Kalivas, 2009; 
Lecca et al., 2007; Madayag et al., 2010). Moreover, continued drug use 
produced maladaptive functional changes in the VTA, by increasing the strength 
of excitatory inputs along with a reduction in inhibitory input (Chen et al., 2010).  
Research continues to elucidate specific mechanisms by which different 
drugs disrupt tonic and phasic DA signaling in MVM DA and other circuits, the 
functional significance of this disruption, and the cellular and molecular 
substrates by which drugs modify synapses and circuits. The initial stages of 
addiction likely involve the acquisition of excessive incentive–motivational 
properties by drug conditioned stimuli, as a result of drugs effectively ‘stamping-
in’ maladaptive associations between the primary reinforce and drug cues via the 
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coincident activation of the MVM DA pathway (Di Chiara, 1999; Ikemoto and 
Panksepp, 1999; Robinson and Berridge, 1993). Furthermore, the development 
of addiction (e.g. progression from actions to habits to compulsive behavior) 
coincides with the progression of neuronal adaptations from limbic to cortical 
areas, from ventromedial to dorsolateral striatal systems, and from dopaminergic 
to glutamatergic control (Everitt and Robbins, 2005; Kalivas, 2009; Lane et al., 
2010; Schmidt and Pierce, 2010; Sesack and Grace, 2010). 
 Acute Reinforcing and Dopamine Neuronal Stimulating Effects of Cocaine within 
the Mesoaccumbens Circuit 
 
Abused drugs (e.g. ethanol, cocaine, nicotine, amphetamine, morphine, 
THC) produced increased levels of DA in the Acb (Di Chiara and Imperato, 
1988), albeit often through divergent substrates (Koob et al., 1998). For example, 
cocaine binds to norepinephrine, serotonin, and DA transporters (NET, SERT, 
and DAT, respectively) to inhibit the uptake of these neurotransmitters (Reith et 
al., 1986; Ritz et al., 1990). While the potency for cocaine reinforcement is 
strongly correlated with the affinity at the DAT (Ritz et al., 1987), knockout 
studies suggest SERT also plays a significant role in cocaine reinforcement (Filip 
et al., 2005; Hall et al., 2004; Sora et al., 2001). The net effect of cocaine to 
increase DA levels in the Acb activates local D1 and D2 receptors, and the 
concurrent stimulation of these receptors is required for cocaine sensitization 
(Henry et al., 1998). Injections of cocaine into the AcbSh, but not the AcbC, 
produced locomotor activation, CPP, and operant responding for self-infusion 
(Filip and Siwanowicz, 2001; Ikemoto, 2002; Katner et al., 2011; Liao et al., 2000; 
Rodd-Henricks et al., 2002a). The local effects of cocaine on DAoutput require 
neuronal impulse flow (Nomikos et al., 1990), both in the VTA (Chen and Reith, 
1994a) and in the Acb (Westerink et al., 1987). Furthermore, VTA DA neuronal 
firing is required for cocaine to increase DA levels within the AcbSh (Aragona et 
al., 2008; Sombers et al., 2009).  
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In human imaging studies, VTA activation was associated with the 
subjective experience of euphoria following cocaine administration (Breiter et al., 
1997; Breiter and Rosen, 1999). In animals, injections of cocaine into posterior 
portions of the VTA produced behavior sensitization and operant responding for 
self-infusion (Cornish and Kalivas, 2001; David et al., 2004; Rodd et al., 2005a). 
Similar to the Acb, cocaine inhibited monoamine uptake within the VTA, 
increasing local levels of DA, serotonin, and norepinephrine (Chen and Reith, 
1994a,b). While the relative uptake potency has not been examined in the VTA, 
cocaine was more potent inhibiting serotonin versus DA uptake in the Acb 
(Matecka et al., 1996; Uchimura and North, 1990). Cocaine-induced increases in 
VTA serotonin levels activated local serotonin type 1B receptors (5-HT1B), 
serotonin type 2A receptors (5-HT2A), and 5-HT3 receptors to putatively stimulate 
VTA DA neurons and increase DA levels in the Acb (McMahon and Cunningham, 
2001; O’Dell and Parsons, 2004; Rodd et al., 2005a).  
Furthermore, cocaine potentially acts indirectly through local glutamatergic 
functioning to increase VTA DA neuronal activity. Stimulation of glutamatergic 
tone to the VTA induced burst firing of DA neurons and increased the number of 
spontaneously active DA neurons (Kalivas, 1993; White, 1996). Cocaine-induced 
increases in VTA DA levels activated presynaptic D1 receptors to increase local 
glutamate levels (Kalivas and Duffy, 1995), while D1 receptor blockade in the 
VTA reduced the reinforcing effects of IVSA cocaine (Ranaldi and Wise, 2001). 
Moreover, impairment of VTA glutamatergic function attenuated: responding for 
cocaine conditioned stimuli (You et al., 2007), the acquisition of cocaine CPP 
(Harris and Aston-Jones, 2003), and behavioral sensitization to cocaine (Kalivas 
and Alesdatter, 1993). A single injection of cocaine, amphetamine, nicotine, 
morphine, or ethanol produced both a long-term potentiation (LTP) of excitatory 
glutamate synapses (Saal et al., 2003) and an impairment of LTP of inhibitory 
GABA synapses (Guan and Ye, 2010; Niehaus et al., 2010) on VTA DA neurons.  
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 Chronic Ethanol Exposure: Effects on Neurobiology and Behavior 
 
Ethanol appears to produce acute reinforcement through direct activation 
of VTA DA neurons (Brodie et al., 1999; Gessa et al., 1985; Verbanck et al., 
1990). Chronic ethanol exposure produces neuronal alterations in dopaminergic 
functioning in both the Acb and VTA (Fadda and Rossetti, 1998; Vengeliene et 
al., 2008). For example, chronic continuous voluntary ethanol drinking by alcohol-
preferring rats produced an up-regulation in dopaminergic functioning within the 
Acb. Specifically, ethanol-drinking experience produced increased extracellular 
DA levels (Thielen et al., 2004), decreased D2 autoreceptor function (Engleman 
et al., 2003), accelerated DA uptake (Carroll et al., 2006), and increased the 
effectiveness of a DAT-inhibitor to increase extracellular DA levels (Engleman et 
al., 2000). In the VTA, chronic ethanol drinking by alcohol-preferring rats 
increased the number of spontaneously active VTA DA neurons (Morzorati et al., 
2010), while decreasing pVTA DA levels (Engleman et al., 2011). Furthermore, 
chronic voluntary ethanol drinking in outbred rats increased the number of DAT 
binding sites in the Acb and VTA (Jiao et al., 2006). Chronic ethanol drinking 
increased the sensitivity of VTA DAneurons to the DA-neuronal-stimulating and 
reinforcing effects of ethanol (Brodie, 2002; Rodd et al., 2005b,c). In addition, 
repeated local injections of ethanol sensitized pVTA DA neurons to the 
stimulating actions of ethanol (Ding et al., 2009a). Chronic ethanol drinking also 
influenced subsequent behavioral and neurobiological responses to cocaine. 
Wistar rats with ethanol-drinking experience displayed a greater increase 
in Acb DA in response to the local application of cocaine compared to naïve 
controls (Yoshimoto et al., 2000), and mice with repeated ethanol exposure 
displayed a CPP for cocaine associated with enhanced synaptic plasticity of 
NMDA receptors on VTA DA neurons (Bernier et al., 2011).  Furthermore, Wistar 
rats with high levels of ethanol drinking were more sensitive to cocaine CPP and 
locomotor activation than low ethanol-drinking rats (Stromberg and Mackler, 
2005). Other studies also observed an enhanced locomotor response to cocaine 
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after chronic ethanol exposure (Hopf et al., 2007; Manley and Little, 1997) Rats 
with high levels of operant lever responding for oral ethanol subsequently 
displayed a more rapid acquisition of lever responding for IVSA cocaine 
compared to animals with lower levels of ethanol responding (Mierzejewski et al., 
2003). Chronic ethanol exposure produced abolished the subsequent 
conditioned taste aversion to cocaine seen in ethanol-naïve animals (Kunin et al., 
1999; Grakalic and Riley, 2002).  
Other drugs of abuse produced neurobiological and behavioral alterations 
similar to those seen with chronic ethanol exposure. For example, chronic 
ethanol, cocaine, or morphine treatment increased levels of NMDA type 1 
(NMDAR1) and glutamate type one (GluR1) ionotropic glutamate receptor 
subunits, while decreasing levels of the GABA receptor A (GABAA) alpha-1 
subunit in the VTA (Fitzgerald et al., 1996; Ortiz et al., 1995). Repeated systemic 
ethanol, nicotine, morphine, or cocaine treatments produced an enhanced 
locomotor response to a subsequent injection of cocaine, associated with a long-
term enhancement of evoked DA and ACh release in the Acb (Nestby et al., 
1997). Repeated cocaine or ethanol injections produced an enhanced locomotor 
response to a subsequent injection with the opposite drug, an effect associated 
with an increased number of striatal DAT binding sites (Itzhak and Martin, 1999).  
 Genetic Factors Associated with Drug and Alcohol Abuse 
 
An increased risk for the development of a drug or alcohol use disorder is 
significantly greater for those with an identified genetic risk factor (Heath et al., 
1997; Lopez-Quintero et al., 2011b; Nurnberger et al., 2004). These risks are 
often associated with differences in the expression of specific genes associated 
with neurotransmission (Edenberg and Kranzler, 2005; Kohnke, 2008). 
Moreover, certain genes are associated with multiple substance use disorders, 
such as the gene encoding the tackykinin 3 receptor, which is associated with 
both alcohol and cocaine dependence (Foroud et al., 2008).  
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Animal research has attempted to investigate the role of genetic 
background on drug and alcohol use and abuse through the characterization of 
individual differences in outbred rat strains or with the selective breeding of a 
specific phenotype from a heterogeneous stock of animals. Selective bi-
directional breeding has established high- and low-alcohol drinking lines to serve 
as reliable models for assessing genetic predispositions associated with the 
contrasting extremes of alcohol use observed in human populations (Murphy et 
al., 2002). To date, bi-directional breeding for ethanol preference versus non-
preference has produced five sets of alcohol-preferring and -nonpreferring lines. 
These include the University of Chile A and B lines (Mardones and Segovia-
Riquelme, 1983), the Sardinian alcohol-preferring/nonpreferring lines (Colombo, 
1997), the ALKO alcohol/nonalcohol lines (Eriksson, 1968), the Indiana 
University alcohol-preferring/nonpreferring (P/NP) lines (Lumeng et al., 1977), 
and the Indiana University high/low alcohol-drinking replicate lines (Li et al., 
1993). The Indiana P rat line, derived by selective breeding from an outbred 
Wistar stock, has been thoroughly tested and found to fulfill the necessary criteria 
for an animal model of alcoholism originally proposed by Lester and Freed (1973) 
and Cicero (1979).  
The P line of alcohol-preferring rats will orally self-administer significant 
levels of ethanol; reach pharmacologically relevant blood ethanol levels (200 
mg%) during 24-h free-choice ethanol drinking; consume alcohol for 
pharmacological effects and not caloric value or taste; work for the operant oral, 
intracranial, and intragastric self-administration of ethanol to show positive 
reinforcement; show expression of functional and metabolic tolerance after 
chronic consumption of ethanol; and show withdrawal symptoms (a sign of 
dependence) after chronic ethanol consumption and termination of ethanol 
access (McBride and Li, 1998; Murphy et al., 2002). In addition, the P line also 
meets an additional criterion proposed by McBride and Li (1998) – the alcohol-
deprivation effect. P rats show an alcohol-deprivation effect, represented by a 
transitory increase in the level of ethanol consumption after a single period or 
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multiple periods of forced abstinence. The alcohol-deprivation effect may be a 
useful model for studying the human phenomenon of relapse, ‘loss of control’, or 
‘binge’ drinking (Murphy et al., 2002).  
P and NP rats represent two divergent neurobiological phenotypes of 
alcohol preference. P rats, compared to NP rats, had significantly lower levels of 
serotonin and the primary metabolite 5-hydroxyindoleacetic acid in a number of 
cortical and limbic regions, including the Acb (Murphy et al., 1982, 1987). 
Appropriately, P rats had less dense serotoninergic innervation of many of these 
regions, including the Acb, than NP rats (Zhou et al., 1991). P and NP rats also 
displayed differences in serotonin receptor densities in a number of limbic brain 
regions (Murphy et al., 2002). Moreover, P rats had lower levels of DA and the 
metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid in the Acb and 
fewer dopaminergic projections from the VTA to the Acb, compared to NP rats 
(Murphy et al., 1982, 1987; Zhou et al., 1995). Compared to NP rats, P rats 
possessed pVTA DA neurons with more action potentials in bursts and a greater 
number of bursts (Morzorati and Marunde, 2006). Lastly, P rats had relatively 
higher densities of mu-opioid receptors in the AcbSh and AcbC, but lower levels 
of CRF in the amygdala (Ehlers et al., 1992; McBride et al., 1998).  
In addition to alcohol-preference and neurobiology, high and low alcohol-
preferring lines were characterized by phenotypic differences in the response to 
other drugs of abuse. Alcohol-preferring rats were more sensitive to the effects of 
cocaine compared to alcohol-non-preferring and outbred rat strains when 
measured by: operant reinforcement (Katner et al., 2011; Marttila et al., 2007), 
locomotor activation (Honkanen et al., 1999; Mikkola et al., 2002), AcbSh 
dopaminergic response (Leggio et al., 2003), neurochemical sensitization of 
AcbSh DA (Mikkola et al., 2001), and drug-induced reinstatement of cocaine-
seeking behavior (Le et al., 2006). In addition, peripheral injections of either 
cocaine or ethanol produced significantly greater Acb DA release in mice bred for 
sensitivity to the locomotor activating effects of ethanol compared to ethanol-
insensitive mice (Meyer et al., 2009). Selective breeding for alcohol preference 
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potentially produced pleiotropic effects of the genes underlying the selected 
phenotype for a general preference for drugs of abuse.  
Reciprocal genetic factors may affect both the intake of sweetened 
substances and drug self-administration (Carroll et al. 2008). Compared to rats 
selectively bred for saccharin non-preference (LoS), rats bred for saccharin 
preference (HiS) displayed enhanced acquisition, maintenance, escalation, 
extinction, and reinstatement of cocaine IVSA (Carroll et al., 2002, 2007, Dess et 
al., 1998; Perry et al., 2006). HiS animals also displayed a greater cocaine-
induced locomotor activation and a potentiated locomotor sensitization compared 
to LoS animals (Carroll et al., 2007). In addition to selective breeding, studies 
also examined individual differences in drug-related behaviors. A model of 
spontaneous addiction liability characterizing rats by the locomotor activity to a 
novel environment was developed, resulting in a divergent response to 
psychostimulants between high-responder (HR) and low-responder (LR) to 
novelty rats. Compared to LR rats, HR rats: exhibited a greater locomotor and 
Acb dopaminergic response to cocaine or amphetamine (Hooks et al., 1991, 
1992; Piazza et al., 1989), acquired cocaine or amphetamine IVSA more rapidly 
(Marinelli and White, 2000; Piazza et al., 1990), were quicker to escalate cocaine 
intake (Grimm and See, 1997), displayed increased maximal responding at peak 
doses of cocaine (Piazza et al., 2000), and more robust and persistence 
increases in VTA DA neuronal firing during acute withdrawal from cocaine 
(McCutcheon et al., 2009). The interactions between genetic background and 
drug exposure also produced unique behavioral effects. For example, repeated 
ethanol injections increased basal DA levels in P and Wistar rats, but not NP rats 
(Smith and Weiss, 1999). Ethanol exposure also increased basal serotonin levels 
in NP and Wistar rats, but decreased levels in P rats. 
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 Objectives and Experimental Rationale 
 
The objectives of the present study are to determine if chronic continuous 
ethanol-drinking experience produces: (1) alterations in the sensitivity of the 
AcbSh to the reinforcing effects of cocaine, (2) changes in the magnitude and 
time course of the local stimulating effects of cocaine on pVTA DA neurons, (3) a 
persistence of alterations in the stimulating effects of cocaine after a period of 
protracted abstinence. The first hypothesis is that long-term continuous voluntary 
ethanol-drinking experience will produce an increased sensitivity to the 
reinforcing effects of cocaine within the AcbSh of P rats. This will be evidenced 
by the ability of a previously subthreshold dose of cocaine to reliably support self-
administration on a fixed ratio (FR) schedule of reinforcement (i.e. leftward shift 
in the dose-response curve). The second hypothesis is that the protocol of 
ethanol drinking from Experiment 1 will produce an increase in the local 
stimulating effects of cocaine on pVTA DA neurons. This will be evidenced by the 
ability of a previously subthreshold dose of intra-pVTA cocaine to produce a 
significant increase in AcbSh DA release The ability of suprathreshold doses to 
produce a greater maximal dopaminergic response (i.e. upward shift in the dose-
response curve) would also support the second hypothesis. The third hypothesis 
is that the potential alterations in the local stimulating effects of cocaine on pVTA 
DA neurons observed in Experiment 2 will remain after a 30-d period of 
protracted abstinence from ethanol drinking. This will be evidenced by similar 
profiles of AcbSh dopaminergic response across the range of cocaine doses 
examined for ethanol-abstinent rats relative to animals with continuous ethanol-
drinking experience. The current experiments will determine if chronic continuous 
voluntary ethanol drinking by animals selectively bred for ethanol preference and 
resulting in moderate to high levels of ethanol intake: (1) initiates alterations in 
the sensitivity to the reinforcing effects of cocaine within the AcbSh and (2) 
produces long-lasting functional changes in cocaine-evoked mesolimbic DA 
neurotransmission associated with changes in reinforcement.  
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The rationale for this study is supported by evidence suggesting 
polysubstance abuse: was more common than misuse of a single drug of abuse, 
was more likely to occur in those with a genetic predisposition to substance 
abuse, and generally occurred in a sequence with the initiation of ‘gateway’ drug 
(e.g. alcohol) use preceding the initiation of illicit drug (e.g. cocaine) use. Ethanol 
and cocaine use activates reinforcement circuitry in similar manner, albeit 
through distinct mechanisms of action. As a result, chronic ethanol drinking has 
the potential to produce functional alterations in cocaine’s central effects via 
ethanol-induced plasticity to reinforcement substrates unique to cocaine, as well 
as through changes in shared targets. Animal models can examine the effects of 
so-called ‘gateway’ drugs on the initiation and escalation of illicit drug use at a 
number of levels, including molecular, neurotransmitter, electrophysiological, 
systems, and behavioral. These experimental studies control factors with 
significant influence in clinical studies, such as the relative drug availability. 
Moreover, animal models of drug and alcohol also examined genetic 
contributions to drug use and maladaptive behavioral profiles, providing an 
additional line of evidence to complement human genetic studies.  
Results demonstrating chronic ethanol-drinking experience contributed to 
an increased sensitivity to the central reinforcing and neuronal activating effects 
of cocaine would support the concept of alcohol as a ‘gateway’ drug to increase 
the likelihood of future cocaine use. Translationally, these findings would suggest 
effective behavioral and/or pharmaceutical interventions would not only reduce 
the initiation and escalation of alcohol drinking, but could also reduce the risk of 
progression to illicit drug use. Future experimental studies should elucidate the 
genetic contributions of the observed effects, as well as the putative substrates of 
ethanol-induced adaptations. This, in turn, could identify human risk factors and 
develop targeted pharmaceutical treatments. 
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2. METHODS 
 Animals 
 
Selectively-bred adult female P rats from the 61st to 68th generations, 
weighing 220 to 280 g at the time of initial ethanol exposure, were obtained from 
the Indiana University breeding colony. Rats were pair-housed inside standard 
opaque plastic tubs upon arrival and were maintained on a 12-h reverse 
light/dark cycle (lights off at 1000 hr) in a temperature and humidity controlled 
environment. Food and water were freely available except in the test chambers. 
All experimental procedures, including surgery, ICSA, and microdialysis were 
conducted during the dark phase.  
The current study used female P rats because females maintain body 
weight and head size better than males, producing more accurate stereotaxic 
placements (Rodd et al., 2004a,b, 2005a,b,c,d; Rodd-Henricks et al., 2000a, 
2003). Although it is possible to delineate the anterior and posterior VTA in male 
P rats, small variations in skull thickness and shape (which appear to be greater 
in male than female rats) require alteration of coordinates from animal to animal, 
reducing placement reproducibility. Most of our previous ICSA studies used 
female rats (Gatto et al., 1994; Rodd et al., 2003b, 2004a, 2005 a,b,c,d; Rodd-
Henricks et al., 2000a, 2002a,b, 2003). Although not systematically studied, the 
estrous cycle did not appear to significantly alter self-administration behavior, as 
indicated by stable responding across several sessions when the same 
concentration of ethanol (Rodd-Henricks et al., 2003) was given. Furthermore, a 
significant gender effect for the self-infusion of ethanol was not observed in a 
recent study using male rats (Rodd et al., 2004b). Lastly, peripheral 
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administration of ethanol produced the same brain ethanol pharmacokinetic 
profile across different stages of the estrous cycle (Crippens et al., 1999; 
Robinson et al., 2002), although the rate of ethanol clearance within the brain 
may be different between males and females (Robinson et al., 2002). 
Additionally, no consistent effects of estrous cycle in female P rats were 
observed in previous studies on DA efflux (Ding et al., 2009a,b; Engleman et al., 
2003; Kohl et al., 1998) 
Animals used in this experiment were maintained in facilities fully 
accredited by the American Association for the Accreditation of Laboratory 
Animal Care. All research protocols were approved by the institutional animal 
care and use committee and are in accordance with the guidelines of the 
Institutional Care and Use Committee of the National Institute on Drug Abuse, 
NIH, and the Guide for the Care and Use of Laboratory Animals (National 
Research Council, 1996). For ICSA experiments, the number of animals 
indicated for each experiment represents approximately 90% of the total number 
undergoing surgery. The remaining 10% were not included in the analysis 
because their injection sites could not be verified due to the loss of the cannulae 
or because the animal failed to complete all experimental test sessions. For 
microdialysis experiments, the number of animals indicated for each experiment 
represents approximately 80% of the total number undergoing surgery. The 
remaining 20% were not included in the analysis because: the injection sites 
could not be verified due to the loss of the cannulae, the animal did not survive 
probe implantation, an insufficient sample volume was collected during 
microdialysis, or complications with high performance liquid chromatography 
(HPLC) sample analysis occurred. 
 Drinking Procedures 
 
After a 2-wk habituation to the home-cage room, animals received access 
to either water alone (ethanol-naïve; N) or water and 15% v/v ethanol solution 
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(continuous ethanol; CE) for at least 12 wk before stereotaxic surgery.  For 
microdialysis experiments, an additional group of animals received access to 
water and 15% v/v ethanol solution for at least 12 wk followed by 30 d with water 
alone (ethanol-abstinent; Ab). Animals were handled and weighed on weekdays. 
Weights of the ethanol solution were monitored and recorded during the final 9 
wk of drinking. Beginning 14 d before surgery, ethanol access was removed for 
one hr/d for the CE group. The length ethanol deprivation was incrementally 
increased during the following 7 d to a final duration of 4 hr/d. Nearly all past 
operant and free-access ethanol-drinking experiments utilizing P rats used 15% 
v/v ethanol, a concentration at which P rats display high levels of intake and 
preference. Ethanol intakes were converted to g/kg/d. 
 Chemical Agents 
 
MgCl2*6H2O, Na2HPO4*7H2O, H3PO4, ethylenediaminetetraacetic acid 
disodium salt dehydrate (EDTA), 1-octanesulfonic acid sodium salt (OSA), 
methanol, NaCl, and D-glucose were obtained from Sigma (St. Louis, MO). KCl, 
CaCl2*2H2O, MgSO4, KH2PO4, and NaHCO3 were obtained from Fisher Scientific 
(Fair Lawn, NJ). The artificial cerebrospinal fluid (aCSF) vehicle for ICSA or 
microinjection consisted of 120.0 mM NaCl, 4.75 mM KCl, 1.2 mM KH2PO4, 1.2 
mM MgSO4, 25.0 mM NaHCO3, 2.5 mM CaCl2*2H2O, and 10.0 mM D-glucose. 
The 2.5 mM concentration of CaCl2*2H2O has been commonly used for in vitro 
electrophysiological studies (Bonci and Malenka, 1999; Brodie et al., 1990) and 
ICSA studies (Ikemoto et al., 1997a; Rodd-Henricks et al., 2000a; 2002a). 
Cocaine HCl was obtained from the National Institute on Drug Abuse (Bethesda, 
MD). Cocaine was dissolved into the aCSF solution at the desired concentration 
and the pH was adjusted to 7.2 to 7.4 using 0.1 N HCl or 0.1 N NaOH prior to 
use. Microdialysis aCSF consisted of 145.0 mM NaCl, 2.7 mM KCl, 1.0 mM 
MgCl2*6H2O, 1.2 mM CaCl2*2H2O, and 2.0 mM Na2HPO4*7H2O, with the pH 
adjusted to 7.2 to 7.4 using 0.1 N HCl or 0.1 N NaOH prior to use. 
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 Histology 
 
At the termination of each experiment, the animals were euthanized with a 
fatal dose of inhaled carbon dioxide. Bromophenol blue (1%) was injected into 
the infusion site for 30 s at a rate of 1.0 µl/min. For microdialysis experiments, 
bromophenol blue was also perfused through the probes. Brains were quickly 
removed and immediately frozen at -70°C. Frozen brains were allowed to 
equilibrate at -15°C in a cryostat microtome before being sliced into 40-µm 
sections. Sections were stained with cresyl violet and examined under a light 
microscope for precise identification of the injection site using the rat brain atlas 
of Paxinos and Watson (2005). Additionally, a second individual, blind to the 
subjects’ group assignment, verified all histologies. 
 Sensitization of Cocaine Reinforcement within the Nucleus Accumbens Shell 
Following Chronic Ethanol Drinking 
 Animal Preparation 
 
While under isoflurane anesthesia, a unilateral 22-gauge guide cannula 
(Plastics One Inc., Roanoke, VA) was stereotaxically implanted into the right 
hemisphere of each subject, aimed 1.0 mm above the AcbSh from a 10° angle to 
the vertical. Coordinates (Paxinos and Watson, 2005) for placements into the 
AcbSh were 1.7 mm anterior to bregma (AP +1.7 mm), 2.3 mm lateral to the 
midline (ML +2.3 mm), and 7.5 mm ventral from the surface of the skull (DV -7.5 
mm). Coordinates for placements into the AcbC or ventral to the AcbSh were AP 
+1.4 mm, ML +2.6 mm, DV -7.0 mm or AP +1.4 mm, ML +2.3 mm, DV -8.0 mm, 
respectively. In between experimental sessions, a 28-gauge stylet was placed 
into the 22-gauge guide cannula and extended 0.5 mm beyond the tip of the 
guide. Rats were single-housed following surgery. Each subject was handled for 
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at least 5 min daily following the third recovery d. Subjects were not acclimated to 
the test chamber prior to the commencement of data collection, nor were they 
previously trained on any operant paradigm. 
 Intracranial Self-administration Apparatus 
 
The test chambers (30 x 30 x 26 cm, width x height x depth) were situated 
in sound-attenuating cubicles (64 x 60 x 50 cm; Coulbourn Instruments, 
Allentown, PA), which were illuminated by a dim house light during testing. Two 
identical levers (3.5 x 1.8 cm) were mounted on a single wall of the test chamber, 
15 cm above a grid floor, and were separated by 12 cm. Levers were raised to 
this level to avoid accidental brushing against the lever and to reduce responses 
as a result of general locomotor activity. Directly above each lever was a row of 
three different colored cue lights. The light (red) to the far right over the active 
lever was illuminated during resting conditions. A desktop computer equipped 
with an operant control system (L2T2 or Graphic State 3.0; Coulbourn 
Instruments) recorded the data and controlled the delivery of infusate in relation 
to lever response. An electrolytic microinfusion transducer (EMIT) system 
developed by Criswell (1977; see Bozarth and Wise, 1980; Goeders and Smith, 
1987) was used to control injections of drug or vehicle. Briefly, two platinum 
electrodes were placed in an airtight drug reservoir (28 mm in length x 6 mm in 
diameter) equipped with a 28-gauge injection cannula (Plastics One, Roanoke, 
VA). The electrodes were connected by a spring-coated cable (Plastics One) and 
swivel (model 205; Mercotac, Carlsbad, CA) to a constant current generator 
(MNC, Shreveport, LA or A-M Systems, Sequim, WA). A 10 µA of quiescent 
current was used to maintain electrodes in a ready state without ejecting or 
aspirating any solution. The current generator was calibrated to produce 225 µA 
of current between the electrodes during infusion. 
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Depression of the active lever delivered the infusion current for five s, 
which led to the rapid generation of hydrogen gas (raising the pressure inside the 
airtight cylinder) and, in turn, forced 100 nl of the solution through the injection 
cannula into the brain. During the 5-s infusion and additional 5-s time-out period, 
the house light and right cue light (red) were extinguished, and the left cue light 
(green) over the active lever flashed on and off at 0.5-s intervals. Depression of 
the inactive lever did not result in any infusion. See Figure 1 for an illustration of 
the EMIT apparatus. The amount of drug infused is directly related to the amount 
of hydrogen gas generated, which is directly proportional to the current intensity 
and duration, as well as the gas constant (Criswell, 1977). The EMIT system was 
calibrated prior to the experiments and once each month subsequently. 
 General Test Condition 
 
For CE groups, ethanol bottles were removed 4 h before the 
commencement of ICSA, in order to minimize any appreciable blood ethanol 
levels. Seven d after surgery, subjects were brought to the testing room, the 
stylet removed, and the injection tank carefully screwed into place. Rats were 
placed individually in the test chambers with the injection needles extended 1.0 
mm beyond the tip of the guide. To avoid trapping air at the tip of the injection 
needle, the infusion current was delivered for five s during insertion of the 
injector, resulting in a single non-contingent administration of drug or vehicle 
(priming) at the beginning of the session. No shaping technique was used to 
facilitate the acquisition of lever responses. The L2T2 or Graphic State 3.0 
computer program recorded the number of infusions and responses on the active 
lever. The program also recorded inactive lever responses, which did not 
produce infusions. Depression of the active lever (FR1 schedule of 
reinforcement) caused the delivery of a 100-nl bolus of solution over a 5-s period 
followed by a 5-s time-out period. The program also recorded active lever 
responses during both the infusion and time-out periods, when responses did not 
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produce additional infusions. The assignment of active and inactive lever with 
respect to left or right position was counterbalanced among subjects. However, 
the active and inactive levers remained the same for each subject throughout the 
experiment. The duration of each experimental session was 4 hr, and sessions 
occurred every other day at the same time (approximately 1400-2000 hr).  
 
 
Figure 1. Photograph of rat depressing on the active lever for an injection of 
infusate (top) and a diagram of the electrolytic microinfusion transducer (EMIT) 
system used for the intracranial self-administration (ICSA) of cocaine solution 
(bottom; adapted from Bozarth and Wise, 1980 and Criswell, 1977). 
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 Experimental Groups 
 
For both the N and CE groups, animals with cannula aimed at the AcbSh 
were randomly assigned to one of seven groups (n = 6-7/group). Vehicle groups 
received infusions of aCSF for all eight sessions. All other groups received 
infusions of 10, 50, 100, 200, 400, or 800 pmol / injection (0.1-8.0 mM) cocaine 
for the Sessions 1-4 and Session 8. These groups received the vehicle (aCSF) 
alone for Sessions 5-7. For both N and CE pretreatment, animals with 
placements aimed dorsolateral (e.g. AcbC) or ventromedial to the AcbSh were 
assigned to receive infusions of 0.5, 2.0, 4.0, or 8.0 mM cocaine in the 
experimental protocol described previously.  Data from animals assigned to the 
AcbSh, but with histologically verified placements within the AcbC or ventral 
regions, were included with data from the planned anatomical controls. 
 Statistical Analysis 
 
All data were expressed as mean ± standard error of the mean (SEM). 
The initial analysis consisted of a two factor (pretreatment x dose) ANOVA 
performed on the average number of reinforcers infused during the first four 
sessions (acquisition). Further data analysis consisted of a ‘pretreatment x dose 
x session’ mixed ANOVA, with a repeated measure of session, performed on the 
number of active lever responses or infusions in different groups. When 
significant differences were detected, Tukey’s b post-hoc tests were performed to 
compare the number of active lever responses or infusions among different 
groups in each session. When within subject differences were detected, post-hoc 
paired-samples t-tests were used. 
Additionally, for each individual group, lever discrimination was 
determined by ‘lever-type (active or inactive) x session’ mixed ANOVA, with a 
repeated measure of session. When differences were detected, post-hoc paired-
samples t-tests were used to compare active and inactive lever responding for a 
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particular session. Lever discrimination is a key factor used to distinguish 
between reinforcement-contingent behavior and drug-stimulated locomotor 
activation when animals self-administer an agent with stimulant properties (e.g. 
ethanol, cocaine, amphetamine). 
 Persistent Alteration of Posterior Ventral Tegmental Area Dopamine Neurons to 
the Stimulating Effects of Cocaine Following Chronic Ethanol Drinking 
 Animal Preparation 
 
While under isoflurane anesthesia, two guide cannulae (Plastics One Inc.) 
were stereotaxically implanted into the right hemisphere of each subject. One 22-
gauge cannula was aimed 1.0 mm above the pVTA or aVTA for microinjection, 
and one 18-gauge cannula was placed above the ipsilateral AcbSh for 
microdialysis. Both cannulae were placed at a 10° angle to the vertical. 
Coordinates (Paxinos and Watson, 2005) for cannula placements into the pVTA, 
aVTA, and AcbSh were AP -5.7 mm, ML +2.1 mm, DV -8.6 mm; AP -4.8 mm, ML 
+2.1 mm, DV -8.6 mm; and AP +1.7 mm, ML +2.3 mm, DV -5.5 mm, respectively. 
Stylets were placed into both guide cannula when no experiments were being 
conduced. Rats were single-housed following surgery. Following the third 
recovery day, each subject was placed into the microdialysis chamber for 3 h and 
handled for at least 5 min daily. Loop-style dialysis probes (active length 1.5 mm, 
2LA?PN= ^ /KN 1" EJJAN @E=IAPAN  µm, molecular weight cut-off: 13,000 
Dalton, Spectrum Laboratories, Inc, Rancho Dominguez, CA) were constructed 
as previously described (Benveniste and Huttemeier, 1990; Engleman et al. 
2003). Six days after surgery, the animal was placed under anesthesia and the 
loop-style probe was inserted along the rostrocaudal axis into the AcbSh and 
secured with cranioplastic cement as previously described (Kohl et al., 1998). 
Microdialysis probes were inserted 12-24 h before the experiment began. 
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 General Test Condition 
 
As with the ICSA experiments, ethanol access was removed from CE 
animals 4 h before the collection of baseline samples in order to minimize any 
appreciable blood ethanol levels. General dialysis procedures were described 
previously (Engleman et al., 2003; Kohl et al., 1998). Briefly, animals were placed 
into Plexiglas chambers (20x18x15 cm) open at the top and opaque on all but 
one side on the seventh day after surgery. The animals were connected with 20-
gauge polyethylene tubing (PE-20; Becton Dickson & Co., MD) to a syringe 
pump (Harvard Apparatus, Holliston, MA). Microdialysis aCSF was perfused 
through the microdialysis probes at a rate of 1.0 µl/min. After a 80-min washout 
period, four 20-min baseline samples were collected. Then, each rat received 
microinjections of either cocaine (0.25, 0.5, 1.0, or 2.0 mM) or aCSF for 10 min.  
Non-contingent microinjections were accomplished using the EMIT system 
described above. A 28-gauge injection cannula (Plastics One) connected to an 
airtight reservoir was inserted into each animal. The reservoir contained two 
electrodes connected by a spring-coated cable (Plastics One) and swivel (model 
205; Mercotac) to a constant current generator (MNC or A-M Systems).  This 
allowed the animals free movement during experiments. Thirty pulse injections 
were experimentally delivered into the pVTA during the 10-min period. Each 
pulse infused 100-nl bolus of solution over five s followed by a 15-s time-out with 
no infusion. In total, 3.0 ml solution was infused into each animal and the injector 
remained in place for 30 s after infusion to allow pressure equilibration. Six 20-
min samples were collected following the initiation of cocaine microinjections. 
The residence time of the microdialysis probe outlet was 20 min and all analyses 
were adjusted accordingly. All samples were collected into microfuge vials 
containing 5.0 µl of 0.1 normal perchloric acid, frozen immediately in dry ice, and 
stored at -70°C. A previous study indicated no degradation of DA up to one 
month using this procedure (Campbell and McBride, 1995). 
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 Experimental Groups 
 
For all three pretreatment conditions (N, CE, and Ab), animals with 
microinjection cannula aimed at the pVTA were randomly assigned to one of five 
groups (n = 5-7/dose) prior to surgery. Subjects received microinjections of a 
single dose of cocaine (25, 50, 100, or 200 pmol / injection [0.25-2.0 mM]) or 
aCSF. There were 14 total pVTA groups, as there was not a 1.0 mM cocaine 
group for the Ab pretreatment. For the N and CE pretreatments, animals with 
microinjection cannula aimed at the aVTA were randomly assigned to one of 
three groups (n = 3-5/dose). Subjects received microinjections of a single 
concentration of cocaine (0.5 or 2.0 mM) or aCSF. 
 Microdialysis Sample Analysis 
 
DA concentrations were analyzed with a reversed-phase HPLC with 
electrochemical detection as described by Engleman et al. (2006). Briefly, 
samples were loaded into a 10-µl loop and injected into an analytical column 
(BDS Hypersil C18 pioneer, 100 mm X 1 mm, Thermo Fisher Scientific, 
Waltham, MA). The mobile phase (50 mM H3PO4, 0.1 mM EDTA, 0.6mM OSA, 
12.8 mM KCl, 10% v/v methanol, pH 6.0) was delivered by an ESA 582 solvent 
delivery system (Chelmsford, MA). DA was detected by a 3-mm glassy carbon 
microelectrochemical flow cell (VT-03, Antec-Leyden, Palm Bay, FL) and an 
amperometric detector at a potential of +400 mV and a sensitivity set at 100 pA/V 
(Decade II, Antec-Leyden). The outputs from the detector were recorded by a 
chromatography data analysis system (ChromPerfect 4.4.0, Justice Innovations, 
Inc., Palo Alto, CA). The lower limit for DA detection was approximately 0.1 nM. 
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 Statistical Analysis 
 
All data were expressed as mean ± SEM. Microdialysis data were 
normalized and expressed as a percentage of basal values to correct for 
baseline variability. Basal dialysate DA values for each subject were calculated 
as the mean of three determinations prior to the injection of cocaine. Data 
analysis consisted of mixed ANOVAs, with a repeated measure of time, 
performed on the percent baseline DA level. A ‘pretreatment’ one-way ANOVA 
was performed on the average basal levels of extracellular DA. Additionally, the 
values of area under the curve (AUC) for each group were calculated using 
GraphPad Prism 4.0 software (La Jolla, CA) and analyzed with a ‘pretreatment x 
dose’ two-way ANOVA. If significant differences were detected with ANOVAs, 
post-hoc Tukey’s b tests were performed to determine individual differences 
between groups. When within subject differences were detected, post-hoc 
paired-samples t-tests were used. Statistical significance was set at p < 0.05. 
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3. RESULTS 
 Sensitization of Cocaine Reinforcement within the Nucleus Accumbens Shell 
Following Chronic Ethanol Drinking 
 Histology 
 
Figure 2 shows representative placements of injection sites within the 
AcbSh, AcbC, and areas ventral to the AcbSh. Only animals completing all eight 
experimental sessions and with correct placements within one of these sites 
were included for analysis and represent approximately 85% of animals 
undergoing stereotaxic surgery. A total of 122 animals completed the training 
procedure. Ninety rats had placements within the medial portion of the AcbSh, 
while no animals had placements within the ventrolateral AcbSh. As described 
previously, the dorsolateral portion of the AcbSh is more similar to the AcbC than 
to the medial AcbSh in regards to afferent and efferent connectivity, locomotor 
response to locally applied stimulants, and cocaine ICSA (Ikemoto, 2002, 2003, 
2007; Ikemoto et al., 2005). Thirty-two rats had placements outside the AcbSh 
but within the AcbC or regions ventral to the AcbSh. Nine animals from the N 
group (0.5 mM, n = 2; 2.0 mM, n = 4; 8.0 mM, n = 3) and eight animals from the 
CE group (0.5 mM, n = 2; 2.0 mM, n = 3; 4.0 mM, n = 3) had placements within 
regions ventral to the AcbSh. Ten animals from the N group (0.5 mM, n = 4; 4.0 
mM, n = 2; 8.0 mM, n = 4) and five animals from the CE group (0.5 mM, n = 2; 
4.0 mM, n = 3) had placements within the AcbC. 
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Figure 2. Illustration depicts representative, non-overlapping placements of 
injections sites in the forebrain for the self-infusion of cocaine solutions or aCSF 
in P rats. The filled circles represent placements of injection sites within the 
AcbSh. The open circles represent placements of injection sites within the AcbC. 
The open squares represent placements of injection sites ventral to the AcbSh. 
 Ethanol Intake for Chronic Ethanol-drinking Rats 
 
Average daily ethanol intakes for the P rats with chronic continuous 
ethanol-drinking experience (CE) were approximately 5-6 g/kg/d for the first wk 
ethanol consumptions were measured. The final wk before surgery, the average 
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ethanol intake for CE animals was 6.4 ± 0.3 g/kg/d. During the 4-d period 
following surgery, there was a modest decrease in mean ethanol intake (5.6 ± 
0.8 g/kg/d). Ethanol intakes returned to pre-surgery baseline levels and were 
stable at 6.8 ± 0.5 g/kg/d for the 2-d period before ICSA testing began and the 
15-d period of ICSA experiments. Ethanol intakes were in line with previous 
studies using P rats given long-term, concurrent access to water and 15% 
ethanol (Rodd et al., 2005b,c; Rodd-Henricks et al., 2000b). 
 Acquisition of Cocaine Self-infusion: Sessions 1-4  
 
Cocaine concentrations between 0 and 8.0 mM (0-800 pmol / 100 nl) were 
tested to determine the response contingent behaviors of female P rats with (CE) 
or without (N) previous ethanol-drinking experience with injection sites within the 
AcbSh. Condensing the analysis to the average number of infusions received 
during the four acquisition sessions revealed significant main effects of 
pretreatment (F(1,76) = 6.7, p < 0.01) and dose (F(6,76) = 8.9, p < 0.001), but 
not the ‘pretreatment x dose’ interaction (F(1,79) = 1.1, p = 0.39). For N rats, 
there was a significant effect of cocaine dose on the number of self-infusions 
(F(6,37) = 4.7, p < 0.001). Post hoc comparisons (Tukey’s b) indicated the 2.0, 
4.0, and 8.0 mM cocaine groups received significantly more infusions than the 
aCSF and 0.1 mM cocaine groups (p < 0.05; Figure 3). For CE rats, there was a 
significant effect of cocaine dose on the number of self-infusions (F(6,39) = 5.3, p 
< 0.001). Post hoc comparisons (Tukey’s b) indicated animals the 0.5, 1.0, 2.0, 
4.0, or 8.0 mM cocaine groups received significantly more infusions than the 
aCSF and 0.1 mM cocaine groups (p < 0.05). Maintaining a constant cocaine 
dose during analysis allowed for the direct comparison of infusions received 
during acquisition between N and CE animals at each dose of cocaine tested. At 
a concentration of 0.5 mM cocaine, CE rats received significantly more infusions 
than N rats (p < 0.05).  
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Figure 3. Dose-response effects for the acquisition of self-infusion of 0-8.0 mM 
cocaine into the AcbSh of P rats with no ethanol-drinking experience (N) or 
continuous ethanol-drinking experience (CE). Concentration of 0 mM is aCSF 
only. The number of infusions was averaged over Sessions 1-4 for each animal.  
* p < 0.05 (Tukey’s b), significantly greater infusions than ‘N-0’ group; # p < 0.05 
(Tukey’s b), significantly greater infusions than ‘CE-0’ and ‘CE-0.1’ groups;         
+ p < 0.05, significantly greater infusions than the ‘N-0.5’ group. Data are the 
means ± SEM. (n = 6 to 8/dose/pretreatment) 
Overall analysis of the number of self-infusions received across the eight 
sessions revealed significant effects of session (F(7,70) = 22.9, p < 0.001), 
pretreatment (F(1,76) = 19.8, p < 0.001) and dose (F(6,76) = 10.7, p < 0.001), as 
well as significant interaction effects for ‘session x pretreatment’ (F(7,70) = 2.5, p 
< 0.05) and ‘session x dose’ (F(42,450) = 1.9, p < 0.001). Holding pretreatment 
and session constant, the number of infusions was examined for the final 
acquisition session, the three extinction sessions, and the reinstatement session 
(Sessions 4-8). Post hoc analyses were also conducted to compare the number 
of infusions received during each session for each dose of cocaine tested. For N 
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rats, there was a significant effect of cocaine dose for Session 4 (F(6,37) = 3.5, 
both p < 0.01). The 1.0, 2.0, 4.0, and 8.0 mM cocaine groups of N animals 
received more self-infusions than the aCSF group (Tukey’s b, p < 0.05; Figure 4). 
CE rats also displayed a significant effect of cocaine dose for Session 4 (F(6,39) 
= 3.3, p < 0.01). The 0.5, 1.0, 2.0, 4.0 and 8.0 mM cocaine groups of CE animals 
received more self-infusions than the aCSF group (p < 0.05; Figure 5). 
 
 
Figure 4. Dose-response effects for the extinction and reinstatement of self-
infusion of 0.1-8.0 mM cocaine or aCSF into the AcbSh of P rats with no ethanol-
drinking experience (N). * p < 0.05 (Tukey’s b), significantly greater infusions 
than ‘N-aCSF’ group for the same session; - p < 0.05, significantly fewer 
infusions than Session 4 for same dose of cocaine; + p < 0.05, significantly 
greater infusions than Session 7 for same dose of cocaine; @ p < 0.05, 
significantly greater infusions than ‘N-aCSF’ group for the same session and than 
Session 7 for same dose of cocaine; # p < 0.05, significantly greater infusions 
than ‘N-aCSF’ group for the same session and than Sessions 4 and 7 for same 
dose of cocaine. Data are the means ± SEM. (n = 6 to 8/dose/pretreatment) 
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Figure 5. Dose-response effects for the extinction and reinstatement of self-
infusion of 0.1-8.0 mM cocaine or aCSF into the AcbSh of P rats with continuous 
ethanol-drinking experience (CE). * p < 0.05 (Tukey’s b), significantly greater 
infusions than ‘CE-aCSF’ group for the same session; # p < 0.05, significantly 
greater infusions than ‘CE-aCSF’ group for the same session and than Sessions 
4 and 7 for same dose of cocaine. Data are the means ± SEM. (n = 6 to 
8/dose/pretreatment) 
 Extinction of Cocaine Self-infusion: Sessions 5-7  
 
When aCSF was substituted for cocaine during Sessions 5-7, there was 
not a significant effect of initial cocaine dose on the number of infusions received 
by N animals for any Session 5-7 (all F(6,37) < 2.1, all p-values > 0.08). 
However, N animals given 0.1, 0.5, 1.0, or 2.0 mM cocaine did not receive 
significantly fewer infusions during any extinction session compared to Session 4 
(all p-values > 0.05; Figure 4). On the other hand, N animals initially self-infusing 
4.0 or 8.0 mM cocaine received significantly fewer infusions during each of the 
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three extinction sessions compared to Session 4 (all p-values < 0.05). The 
substitution of aCSF for cocaine produced a different effect on self-infusion for 
CE animals compared to their N counterparts. 
During Sessions 5 and 6, CE animals displayed a significant effect of 
initial cocaine dose on self-infusions (both F(6,39) > 3.9, both p-values < 0.01). 
During both Sessions 5 and 6, the 2.0 and 4.0 mM groups received more self-
infusions than the aCSF group (p < 0.05; Figure 5). During Session 7, there was 
not a significant effect of dose on the number of infusions received (F(6,39) = 0.9, 
p= 0.50). In contrast from the N groups, no CE groups received significantly 
fewer infusions during any of the three extinction sessions compared to Session 
4 at any cocaine dose tested (all p-values > 0.05; Figure 5). 
 Reinstatement of Cocaine Self-infusion: Session 8  
 
When access to cocaine self-infusion was restored during Session 8, the 
1.0, 2.0, 4.0, and 8.0 mM cocaine groups of N animals received a greater 
number of infusions compared to Session 7 (all p-values < 0.05; Figure 4). The 
0.5, 1.0, 2.0, and 4.0 mM cocaine groups of CE animals received a greater 
number of infusions during Session 8 compared to Session 7 (all p-values < 0.05; 
Figure 5). To clarify, reinstatement in this case is defined as the return of the 
availability of reinforce following a period of unavailability (Flaherty, 1985). This is 
a distinct concept from ‘reinstatement of responding’, the animal model of drug-
induced seeking (Shaham et al., 2003). 
Analysis revealed significant main effects of pretreatment (F(1,76) = 20.1, 
p < 0.001) and dose (F(6,76) = 6.0, p < 0.001), as well as the ‘pretreatment x 
dose’ interaction (F(1,76) = 2.4, p < 0.05). For N rats, there was a significant 
effect of cocaine dose on the number of self-infusions (F(6,37) = 5.1, p < 0.001). 
Post hoc comparisons (Tukey’s b) for reinstatement indicated the 1.0, 2.0, 4.0, 
and 8.0 mM cocaine groups of N animals received more infusions than the aCSF 
group (p < 0.05; Figures 4 & 6). Additionally, the 2.0 and 4.0 mM cocaine 
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received more infusions than the 0.5 mM cocaine group (p < 0.05). For CE rats, 
there was a significant effect of cocaine dose on the number of self-infusions 
(F(6,39) = 4.1, p < 0.005). Post hoc comparisons (Tukey’s b) indicated the 0.5, 
1.0, 2.0, or 4.0 mM cocaine groups of CE animals received more infusions than 
the aCSF group (p < 0.05; Figures 5 & 6). Comparison of infusions received by N 
and CE rats during Session 8 revealed CE rats received significantly more 
infusions than N rats at concentrations of 0.5, 1.0, 2.0 and 4.0 mM cocaine (all p-
values < 0.05; Figure 6). 
 
 
Figure 6. Dose-response effects for the reinstatement of self-infusion of 0-8.0 
mM cocaine into the AcbSh of P rats with no ethanol-drinking experience (N) or 
continuous ethanol-drinking experience (CE). Concentration of 0 mM is aCSF 
only. The number of infusions was obtained from Session 8 for each animal.        
* p < 0.05 (Tukey’s b), significantly greater infusions than ‘N-0’ group; @ p < 0.05 
(Tukey’s b), significantly greater infusions than ‘CE-0’ group; + p < 0.05, 
significantly greater infusions compared to the N group with the same cocaine 
dose. Data are the means ± SEM. (n = 6 to 8/dose/pretreatment) 
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Figure 7. Comparison of infusions of 0-8.0 mM cocaine into the AcbSh between 
Session 8 () and Session 4 () for P rats with no ethanol-drinking experience 
(N) or continuous ethanol-drinking experience (CE). Concentration of 0 mM is 
aCSF only. * p < 0.05, significantly greater infusions for Session 8 compared to 
Session 4 for the same pretreatment condition and cocaine dose; @ p < 0.05, 
significantly greater infusions for Session 8 compared to Session 4 for the same 
pretreatment condition and cocaine dose and compared to the corresponding N 
group. Data are the means ± SEM. (n = 6 to 8 /dose/pretreatment) 
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Figure 8. Representative infusion pattern for P rats with no ethanol-drinking 
experience (N) or continuous ethanol-drinking experience (CE) self-administering 
either 0.5 or 2.0 mM cocaine or aCSF into the AcbSh or AcbC. Each line 
represents one infusion. The first row of traces represents the initial test session. 
The second row of traces represents the final session of acquisition (Session 4). 
The third row of traces represents the final session of extinction (Session 7). The 
fourth row of traces represents reinstatement (Session 8). (n = 6 to 8 
/dose/pretreatment) 
 
  
49 
Comparison of the number of self-infusions received during Session 8 
compared to Session 4 (Figure 7) revealed significant effects of session (F(1,76) 
= 39.7, p < 0.001), pretreatment (F(1,76) = 18.4, p < 0.001), and dose (F(6,76) = 
7.6, p < 0.001), as well as significant interactions for ‘session x pretreatment’ 
(F(1,76) = 7.6, p < 0.01) and ‘session x dose’ (F(6,76) = 2.3, p < 0.05). For N 
rats, the 2.0 and 4.0 mM cocaine groups received a significantly greater number 
of infusions during Session 8 compared to Session 4 (p < 0.05). For CE rats, the 
0.5, 1.0, 2.0, and 4.0 mM cocaine groups received a significantly greater number 
of infusions during Session 8 compared to Session 4 (1.0 and 2.0 mM: p < 0.005; 
0.5 and 4.0 mM: p < 0.05). 
 Lever Responding of Ethanol-naïve Rats 
 
Overall analysis of the number of active lever responses across all eight 
sessions (Figures 9-11) revealed significant main effects of session (F(7,70) = 
22.3, p < 0.001), pretreatment (F(1,80) = 20.0, p < 0.001) and dose (F(6,80) = 
12.1, p < 0.001), as well as a significant interaction effect for ‘session x 
pretreatment’ (F(7,70) = 3.4, p < 0.005).  
For rats with no ethanol-drinking experience (N), were significant main 
effects of session (F(7,31) = 11.1, p < 0.001) and dose (F(6,37) = 6.3, p < 0.001), 
as well as a significant ‘session x dose’ interaction (F(42,216) = 1.6, p < 0.05). 
For the ‘session x dose’ interaction, individual ANOVAs were performed for each 
session to determine the dose effect. Analysis revealed a significant effect of 
dose during each of the initial four sessions (acquisition; all F(6,37) > 2.6, all p-
values < 0.03). During Session 1, the 1.0 and 2.0 mM cocaine groups responded 
more on the active lever than the aCSF and 0.1 mM cocaine groups (p < 0.05, 
Tukey’s b). During Session 2, the 2.0, 4.0, and 8.0 mM cocaine groups 
responded more on the active lever than the aCSF group, and the 2.0 mM group 
responded more on the active lever than the 0.1 and 0.5 mM cocaine groups (p < 
0.05, Tukey’s b). During Sessions 3 and 4, the 1.0, 2.0, 4.0, and 8.0 mM cocaine 
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groups responded more on the active lever than the aCSF group and the 0.1 and 
0.5 mM cocaine groups (p < 0.05, Tukey’s b). 
 
 
Figure 9. Responses on the active and inactive levers for the self-infusion of 0.1 
mM cocaine or aCSF into the AcbSh of P rats with no ethanol-drinking 
experience (N) or continuous ethanol-drinking experience (CE) for four 
acquisition sessions, three extinction sessions, and one reinstatement session.   
# p < 0.05, significantly greater active lever responses during Session 8 
compared to inactive lever responses for Session 8 and compared to active lever 
responses for Sessions 4 and 7; + p < 0.05, significantly greater active lever 
responses for CE rats compared to active lever responses for N rats at the same 
cocaine dose during the same session. Data are the means ± SEM. (n = 6 to 8 
/dose/pretreatment) 
During the first session of extinction (Session 5) there was no significant 
effect of dose on the level of active lever responding (F(6,37) = 2.0, p = 0.08). 
However, there was a significant effect of dose on active lever responding during 
Sessions 6 and 7 (both F(6,37 > 4.4, p < 0.005). Post hoc analysis (Tukey’s b) 
revealed only the 1.0 mM cocaine group responded more on the active lever 
compared to the aCSF group during Session 6 or 7 (Figures 9 and 10; p <0.05). 
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The aCSF group and the 0.1, 0.5, and 1.0 mM cocaine groups did not display 
significantly different levels of active lever responding during Session 5, 6, or 7 
compared to Session 4 (all p-values > 0.24). The 2.0 mM cocaine group 
displayed reduced active lever responding during Session 6 (but not Session 5 or 
7) compared to Session 4 (p < 0.05). The 4.0 and 8.0 mM cocaine groups 
displayed reduced active lever responding during Sessions 5, 6, and 7 compared 
to Session 4 (all p-values < 0.05).  
When cocaine access for N rats was reinstated during Session 8, there 
was a significant effect of dose on the level of active lever responding (F(6,37) = 
4.0, p < 0.005). The 1.0, 2.0, 4.0, and 8.0 mM cocaine groups responded more 
on the active lever than the aCSF group and the 0.1 and 0.5 mM cocaine groups 
(p < 0.05, Tukey’s b). However, none of the seven N groups responded more on 
the active lever during Session 8 compared to Session 4 (Figures 9-11; all p-
values > 0.20). Additionally, the number of active lever responses during Session 
8 compared to Session 7 was significantly greater the 2.0, 4.0, and 8.0 mM 
cocaine groups (all p-values < 0.04), but not for the aCSF group and the 0.1, 0.5, 
and 1.0 mM cocaine groups (all p-values > 0.06).  
For N rats, the aCSF group and the 0.1 and 0.5 mM cocaine groups did 
not show significant effects of lever-type (all F-values < 2.1, all p-values > 0.20) 
or ‘lever-type x session’ interaction (all F-values < 1.4, all p-values > 0.24) on 
lever responding (Figures 9 and 10). The 2.0, 4.0, and 8.0 mM cocaine groups 
displayed significant effects of both lever-type (all F-values > 13.3, all p-values < 
0.02, Figure 11) and ‘lever-type x session’ interaction (all F-values > 3.2, all p-
values < 0.01). During Sessions 2, 3, 4, and 8, the 2.0, 4.0, and 8.0 mM cocaine 
groups responded significantly more on the active lever than the inactive lever 
(all p-values < 0.04; Figure 11). The 1.0 mM cocaine group showed a marginally 
significant effect on lever responding of lever-type (F(1,6) = 4.7, p = 0.07), but not 
of a ‘lever-type x session’ interaction (F(7,42) = 0.9, p = 0.49). Further analysis 
revealed significantly greater active versus inactive lever responding for the 1.0 
mM cocaine group only during Session 8 (p < 0.05, Figure 10). 
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Figure 10. Responses on the active and inactive levers for the self-infusion of 0.5 
or 1.0 mM cocaine into the AcbSh of P rats with no ethanol-drinking experience 
(N) or continuous ethanol-drinking experience (CE) for four acquisition sessions, 
three extinction sessions, and one reinstatement session. * p < 0.05, significantly 
greater active lever responses compared to inactive lever responses for the 
same session; - p < 0.05, significantly fewer active lever responses during a 
particular extinction session compared to active lever responses during Session 
4; # p < 0.05, significantly greater active lever responses during Session 8 
compared to inactive lever responses for Session 8 and compared to active lever 
responses for Sessions 4 and 7; + p < 0.05, significantly greater active lever 
responses for CE rats compared to active lever responses for N rats at the same 
cocaine dose. Data are the means ± SEM. (n = 6 to 8 /dose/pretreatment) 
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Figure 11. Responses on the active and inactive levers for the self-infusion of 
2.0, 4.0 or 8.0 mM cocaine into the AcbSh of P rats with no ethanol-drinking 
experience (N) or continuous ethanol-drinking experience (CE) for four 
acquisition sessions, three extinction sessions, and one reinstatement session.   
* p < 0.05, significantly greater active lever responses compared to inactive lever 
responses for the same session; - p < 0.05, significantly fewer active lever 
responses during a particular extinction session compared to active lever 
responses during Session 4; ^ p < 0.05, significantly greater active lever 
responses during Session 8 compared to inactive lever responses for Session 8 
and compared to active lever responses for Session 7; # p < 0.05, significantly 
greater active lever responses during Session 8 compared to inactive lever 
responses for Session 8 and compared to active lever responses for Sessions 4 
and 7; + p < 0.05, significantly greater active lever responses for CE rats 
compared to active lever responses for N rats at the same cocaine dose. Data 
are the means ± SEM. (n = 6 to 8 /dose/pretreatment) 
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 Lever Responding of Ethanol-drinking Rats  
 
For rats with continuous ethanol-drinking experience (CE), there were 
significant main effects of session (F(7,33) = 15.9, p < 0.001) and dose (F(6,39) = 
7.1, p < 0.001), and a significant ‘session x dose’ interaction (F(42,228) = 1.5, p < 
0.05). For the ‘session x dose’ interaction, individual ANOVAs were performed for 
each session to determine the dose effect. Analysis revealed a significant effect 
of dose during Sessions 1-4 (all F(6,39) > 2.6, all p-values < 0.03). During 
Session 1, only the 4.0 mM cocaine group responded more on the active lever 
than the aCSF group (p < 0.05, Tukey’s b). During Session 2, the 1.0, 2.0, 4.0, 
and 8.0 mM cocaine groups responded more on the active lever than the aCSF 
group (p < 0.05, Tukey’s b). During Sessions 3 and 4, the 0.5, 1.0, 2.0, 4.0, and 
8.0 mM cocaine groups responded more on the active lever than the aCSF 
group, and 4.0 mM group responded more on the active lever than the 0.1 mM 
cocaine group (p < 0.05, Tukey’s b). 
During Sessions 5 and 6, there was a significant effect of cocaine dose on 
the level of active lever responding (both F(6,39) > 4.6, both p-values  < 0.005). 
During both Sessions 5 and 6, the 2.0 and 4.0 mM cocaine groups responded 
more on the active lever than aCSF group and the 0.1 mM cocaine group (p < 
0.05, Tukey’s b; Figures 9 and 11). On the other hand, there was not a significant 
effect of cocaine dose on the level of active lever responding during Session 7 
(F(6,39) = 2.0, p = 0.09). The aCSF and 0.1 mM cocaine groups did not have 
significantly different levels of active lever responding during Session 5, 6, or 7 
compared to Session 4 (all p-values > 0.18). The 0.5, 1.0, and 8.0 mM cocaine 
groups showed reduced active lever responding during at least two of Sessions 
5-7 compared to Session 4 (all p-values < 0.05; Figures 10 and 11). On the other 
hand, the 2.0 and 4.0 mM cocaine groups did not show reduced active lever 
responding during Session 5, 6, or 7 compared to Session 4 (all p-values > 0.08). 
When cocaine access for CE animals was reinstated during Session 8, 
there was a significant effect of dose on the level of active lever responding 
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(F(6,39) = 5.2, p < 0.001). The 0.1, 0.5, 1.0, 2.0, 4.0, and 8.0 mM cocaine groups 
responded more on the active lever than the aCSF group (p < 0.05, Tukey’s b). 
The 0.1, 0.5, 1.0, 2.0, and 4.0 mM cocaine groups the responded more on the 
active lever during Session 8 compared to both Sessions 4 and 7 (all p-values < 
0.04; Figures 11 and 12). The 8.0 mM cocaine group, however, did not respond 
more on the active lever during Session 8 compared to either Session 4 or 7 
(both p-values > 0.08). 
For CE rats, the aCSF group did not did not show significant effects of 
lever-type (F(1,5) = 0.1, p = 0.90) or ‘lever-type x session’ interaction (F(7,35) = 
0.6, p = 0.75) on lever responding (Figure 9). The 0.5, 1.0, 2.0, 4.0, and 8.0 mM 
cocaine groups displayed significant effects of both lever-type (all F-values > 
12.1, all p-values < 0.02) and ‘lever-type x session’ interaction (all F-values > 2.8, 
all p-values < 0.02). During Sessions 2, 3, 4, and 8, the 0.5, 1.0, 2.0, and 4.0 mM 
cocaine groups responded more on the active lever than the inactive lever (all p-
values < 0.04; Figures 10 and 11). The 8.0 mM cocaine group responded more 
on the active lever than the inactive lever during Sessions 2, 4, and 8 (all p-
values < 0.03). The 0.1 mM cocaine group showed marginally significant effects 
on lever responding of lever-type (F(1,6) = 5.0, p = 0.06) and of a ‘lever-type x 
session’ interaction (F(7,42) = 2.1, p = 0.06). Further analysis revealed 
significantly greater active versus inactive lever responding for the 0.1 mM 
cocaine group only during Session 8 (p < 0.05, Figure 10). 
A comparison of active lever responding between N and CE animals 
during each session at each dose of cocaine revealed significant differences 
during acquisition and reinstatement. During Sessions 3 and 4, the 0.5 and 1.0 
mM cocaine groups of CE animals responded more on the active lever compared 
to N animals receiving the same dose (all p-values < 0.03; Figure 10). 
Additionally, the 0.5 mM cocaine group of CE animals responded more during 
Session 2 on the active lever compared to N animals given the same dose (p < 
0.05). During Session 8, the 0.1, 0.5, 1.0, 2.0, and 4.0 mM cocaine groups of CE 
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animals responded more on the active lever compared to N animals receiving the 
same dose (all p-values < 0.05; Figures 10 and 11). 
 Infusions and Lever Responding of Anatomical Controls  
 
Animals with cannula implanted in the AcbC or ventral to the AcbSh self-
administering 0.5-8.0 mM cocaine received a comparable number of infusions 
during Sessions 1-4 as those administering aCSF or 0.1 mM cocaine into the 
AcbSh (Figure 12).  Analyzing the average number of infusions received by the 
32 anatomical control animals during the four acquisition sessions revealed no 
significant main effects or interactions for site, pretreatment, or dose (all F-values 
< 2.5, all p-values > 0.13). Collapsing the data across dose, the average number 
of infusions received for the first four sessions were 6.1 ± 0.9 and 5.6 ± 1.2 for N 
animals and 10.8 ± 1.9 and 5.8 ± 0.8 for CE animals with placements within the 
AcbC or ventral to the AcbSh, respectively. Overall, cannula placements 
surrounding the AcbSh did not support the acquisition of cocaine self-infusion at 
any of the doses tested for either pretreatment condition. 
AcbC and ventral groups self-administering 0.5-8.0 mM cocaine received 
a comparable number of infusions during Session 8 as those administering aCSF 
or 0.1 mM cocaine into the AcbSh (Figure 12).  Analyzing the average number of 
infusions received by the 32 anatomical control animals during Session 8 
revealed no significant main effects or interactions for site, pretreatment, or dose 
(all F-values < 3.3, all p-values > 0.07). The average number of infusions 
received for the Session 8 was 17.6 ± 4.9 and 12.1 ± 2.3 for N animals and 16.8 
± 2.6 and 16.8 ± 4.9 for CE animals with placements within the AcbC or ventral to 
the AcbSh, respectively.  
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Figure 12. Dose-response effects for the acquisition and reinstatement of self-
infusion of 0.5-8.0 mM cocaine into the AcbC or regions ventral to the AcbSh of P 
rats with no ethanol-drinking experience (N) or continuous ethanol-drinking 
experience (CE). Concentration of 0 mM is aCSF only. For acquisition, the 
number of infusions was averaged over Sessions 1-4 for each animal. For 
reinstatement, the number of infusions was obtained from Session 8 for each 
animal. Data was collapsed across dose into groups with placements within the 
AcbC or ventral to the AcbSh. Infusion data for rats given 0.1 nM cocaine or 
aCSF into the AcbSh is presented for comparison. Data are the means ± SEM. 
(n = 5 to 10/pretreatment for AcbC or ventral to AcbSh) 
Analyzing the number of active lever responses by the control animals 
across the eight sessions revealed a significant effect of session (F(7,15 = 5.7, p 
< 0.005) but no other significant main effects or interactions for site, 
pretreatment, or dose (all F-values < 1.4, all p-values > 0.12). Anatomical control 
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animals performed a comparable number of active lever responses for each 
session as those administering aCSF into the AcbSh (Figure 13). Comparison of 
active and inactive lever responding revealed no significant main effects or 
interactions of lever-type, session, or dose for each of the four groups (N or CE 
animals with placements within the AcbC or the region ventral to the AcbSh; all 
F-values < 3.3, all p-values > 0.07). 
 
 
Figure 13. Responses on the active and inactive levers for the self-infusion of 
0.5-8.0 mM cocaine into the AcbC or regions ventral to the AcbSh of P rats with 
no ethanol-drinking experience (N) or continuous ethanol-drinking experience 
(CE) for four acquisition sessions, three extinction sessions, and one 
reinstatement session. Lever responses of rats self-infusing aCSF into the AcbSh 
are presented for comparison. Data are the means ± SEM. (n = 5 to 
10/pretreatment for AcbC or ventral to AcbSh) 
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 Persistent Alteration of Posterior Ventral Tegmental Area Dopamine Neurons to 
the Stimulating Effects of Cocaine Following Chronic Ethanol Drinking 
 Histology 
 
Figure 14 shows representative placements of microinjection sites and 
microdialysis probes, respectively. The primary analysis included animals with 
verified placements within both the pVTA and AcbSh. The pVTA was defined as 
the VTA region at the level of the interpeduncular nucleus, coronal sections at 
5.3 to 6.1 posterior to bregma. The aVTA was defined as the VTA region at the 
level of the mammillary body, coronal sections at 4.8 to 5.2 posterior to bregma. 
Microinjection sites outside of the VTA included neuroanatomical controls within 
adjacent regions: dorsomedial (rostral linear nucleus of the raphe), dorsolateral 
(red nucleus), ventrolateral (medial lemniscus and SN), and ventromedial 
(interpeduncular nucleus). Probe placements with at least 75% of active 
membrane area located within the AcbSh sub-region were classified as AcbSh. A 
number of probe placements spanned portions of the AcbC, OT, or VP. Animals 
with placements within both the pVTA or aVTA and AcbSh represented 
approximately 75% of rats undergoing stereotaxic surgery. A total of 149 animals 
completed the microinjection-microdialysis protocols with sufficient dialysate 
volumes for analysis. Groups with probe placements within the AcbSh and 
microinjection placements within the pVTA, aVTA, or outside the VTA were 
composed of 82, 25, and 36 animals, respectively. There were an additional six 
animals with injection placements within the pVTA and probe placements with at 
least 30% membrane area within the dorsal striatum. 
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Figure 14. Illustration depicts representative, non-overlapping placements of 
microdialysis probes in the forebrain (left) and microinjections sites in the 
midbrain (right) of P rats. The lines represent the 1.5mm length of microdialysis 
probes in the AcbSh. The filled circles represent placements of injection sites 
within the pVTA. The open circles represent placements of injection sites within 
the aVTA. The open squares represent placements of injection sites in regions 
adjacent to the VTA. 
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 Ethanol Intake for Ethanol-drinking and Ethanol-abstinent Rats 
 
Average daily ethanol intakes for the P rats with continuous ethanol-
drinking experience (CE) were approximately 5-6 g/kg/d for the first wk ethanol 
consumptions were measured. The final wk before surgery, the average ethanol 
intake for CE animals was 6.6 ± 0.5 g/kg/d. During the 4-d period following 
surgery, there was a modest decrease in mean ethanol intake (5.7 ± 0.7 g/kg/d). 
Ethanol intakes returned to pre-surgery baseline levels for the 2-d period before 
microinjection-microdialysis experiments. Average daily ethanol intakes for the P 
rats with continuous ethanol-drinking experience followed by a period of 
abstinence (Ab) were approximately 5-6 g/kg/d for the first wk ethanol 
consumption was measured. The final wk before abstinence, the average ethanol 
intake for Ab animals was 6.3 ± 0.4 g/kg/d. Ethanol intakes were in line with 
previous studies using P rats given long-term, concurrent access to water and 
15% ethanol (Rodd et al., 2005b,c; Rodd-Henricks et al., 2000b). 
 Temporal Pattern of the Stimulating Effects of Cocaine on Posterior Ventral 
Tegmental Area Dopamine Neurons 
 
There was no significant difference in the basal extracellular DA levels in 
the AcbSh of animals resulting from drinking experience  (F(2,79) = 1.4, p = 
0.25). Basal DA levels were 1.15 ± 0.06 nM, 1.11 ± 0.06 nM, and 1.01 ± 0.07 nM 
for N, CE, and Ab animals, respectively. These levels are within the range of Acb 
basal extracellular DA levels previously reported for P rats using traditional 
microdialysis (Ding et al., 2009a; Engleman et al., 2000; Melendez et al., 2002). 
The reported values are not corrected for in vivo probe recovery, and definitive 
differences between groups in extracellular DA levels could not be determined 
without conducting quantitative (e.g. zero-net-flux) microdialysis experiments.  
Analysis of percent baseline DA levels revealed significant main effects of 
time (F(7,62) = 17.1, p < 0.001), pretreatment (F(2,68) = 4.7, p < 0.05), and dose 
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(F(4,68) = 51.8, p < 0.001). Significant interaction effects for ‘pretreatment x 
dose’ F(7,68) = 35.3, p < 0.001), ‘time x pretreatment’ (F(14,126) = 2.2, p < 0.01), 
‘time x dose’ interaction (F(28,260) = 4.2, p < 0.001), and ‘time x pretreatment x 
dose’ (F(49,476) = 3.2, p < 0.001) were also found. 
 
 
Figure 15. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of aCSF into the pVTA. N: no ethanol-drinking 
experience; CE: continuous ethanol-drinking experience; Ab: chronic ethanol-
drinking experience followed by abstinence. Data are the means ± SEM. 
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 Nucleus Accumbens Shell Dopaminergic Response After Injection of Artificial 
Cerebrospinal Fluid or 0.25 mM Cocaine into the Posterior Ventral Tegmental 
Area 
 
Figure 15 shows injection of aCSF into the pVTA did not significantly alter 
baseline levels of extracellular DA regardless of pretreatment. Injection of 0.25 
mM cocaine into the pVTA of N, CE, or Ab rats increased extracellular DA levels 
within the AcbSh with a relative magnitude as follows: Ab > CE > N (Figure 16). 
For N animals, DA levels were not elevated to a significant extent (peak = 131 ± 
14% of baseline, all p > 0.06). For CE animals, DA levels gradually increased 
within 20 min after cocaine injection (127 ± 11% of baseline), reached peak 
levels 20 min later (201 ± 28%, p < 0.05), then gradually returned to baseline 
levels at 100 min after cocaine injection. For Ab animals, DA levels sharply 
increased within 20 min after cocaine injection (195 ± 13% of baseline, p < 
0.005), reached a peak 20 min later (232 ± 11%, p < 0.001), then gradually 
returned to baseline levels at 100 min after cocaine injection.  
At 20 min after 0.25 mM cocaine injection, DA levels were significantly 
greater (F(2,14) = 8.7, p < 0.005) for Ab animals compared to both N and CE 
animals (p < 0.005; Figure 16). DA levels were significantly greater (F(2,14) = 
11.3, p < 0.005) for CE and Ab animals compared to N animals at 40 min post-
injection (p < 0.01). At 60 min after injection, DA levels were significantly different 
between all groups (F(2,14) = 13.1, p < 0.001). DA levels at 60 min post-injection 
were greater for Ab animals compared to both CE and N animals (p < 0.05) and 
greater for CE animals compared to N animals (p < 0.05). At 80 min after 
injection, DA levels were significantly greater (F(2,14) = 4.5, p < 0.05) for Ab 
animals compared to N animals (p < 0.05). 
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 Nucleus Accumbens Shell Dopaminergic Response After Injection of 0.5 mM 
Cocaine into the Posterior Ventral Tegmental Area 
 
Figure 17 represents the effects of 0.5 mM cocaine injection into the pVTA 
on extracellular DA levels in the AcbSh of N, CE, or Ab animals. Injection of 0.5 
mM cocaine into the pVTA increased DA levels within the AcbSh for N and (to a 
greater extent) CE animals. Conversely, injection of 0.5 mM cocaine into the 
pVTA of Ab animals did not produce a significant change in DA levels within the 
AcbSh. For N animals, DA levels gradually increased within 20 min after cocaine 
injection (119 ± 6% of baseline), reached peak levels 20 min later (168 ± 10%, p 
< 0.005), then gradually returned to baseline levels at 80 min after cocaine 
injection. For CE animals, DA levels sharply increased to a peak within 20 min 
after cocaine injection (324 ± 51% of baseline, p < 0.01) and then gradually 
returned to baseline levels at 80 min after injection. For Ab animals, DA levels 
immediately decreased 20 min after cocaine injection (79% ± 7 of baseline, n.s. p 
> 0.05) and then gradually returned to baseline levels at 80 min after injection.  
At 20 min after 0.5 mM cocaine injection, DA levels were significantly 
greater (F(2,15) = 19.8, p < 0.001) for CE animals compared to both N and Ab 
animals (p < 0.001; Figure 17). DA levels were significantly different between all 
groups (F(2,15) = 16.9, p < 0.001) 40 min after injection. DA levels at 40 min 
post-injection were greater for CE animals compared to both N and Ab animals 
(p < 0.05) and greater for N animals compared to Ab animals (p < 0.05). At 60 
min after injection, DA levels were significantly greater (F(2,15) = 9.8, p < 0.005) 
for CE and N animals compared to Ab animals (p < 0.05). At 100 min post-
injection, DA levels were significantly greater (F(2,15) = 4.7, p < 0.05) for N 
animals compared to CE and Ab animals (p < 0.05). 
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Figure 16. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 0.25 mM cocaine into the pVTA. N: no ethanol-
drinking experience; CE: continuous ethanol-drinking experience; Ab: chronic 
ethanol-drinking experience followed by abstinence. + p < 0.05, significantly 
greater than baseline levels; # p < 0.05 (Tukey’s b), significantly greater than all 
other groups; * p < 0.05 (Tukey’s b), significantly greater than the ‘N-0.25’ group. 
Data are the means ± SEM. 
  
66 
 
Figure 17. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 0.5 mM cocaine into the pVTA. N: no ethanol-
drinking experience; CE: continuous ethanol-drinking experience; Ab: chronic 
ethanol-drinking experience followed by abstinence. + p < 0.05, significantly 
different from baseline levels; # p < 0.05 (Tukey’s b), significantly greater than all 
other groups; * p < 0.05 (Tukey’s b), significantly greater than ‘Ab-0.5’ group. 
Data are the means ± SEM. 
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 Nucleus Accumbens Shell Dopaminergic Response After Injection of 1.0 mM 
Cocaine into the Posterior Ventral Tegmental Area 
 
For the concentration of 1.0 mM cocaine, data was obtained from N and 
CE animals, but not for Ab animals (Figure 18). Injection of 1.0 mM cocaine into 
the pVTA increased DA levels within the AcbSh of N animals. On the other hand, 
injection of 1.0 mM cocaine into the pVTA of CE animals decreased AcbSh DA 
levels. For N animals, DA levels increased within 20 min after cocaine injection 
(144 ± 10% of baseline, p < 0.01), reached peak levels 20 min later (164 ± 7%, p 
< 0.001), then gradually returned to baseline levels at 80 min after cocaine 
injection. For CE animals, DA levels decreased 20 min after cocaine injection (69 
± 5% of baseline, p < 0.01), reached a minimum level 20 min later (56 ± 4%, p < 
0.001), then gradually returned to baseline levels at 100 min after injection. At 20, 
40, and 60 min after cocaine injection, DA levels were significantly greater for N 
compared to Ab animals (all t-values > 4.2, p-values < 0.005). 
Nucleus Accumbens Shell Dopaminergic Response After Injection of 2.0 mM 
Cocaine into the Posterior Ventral Tegmental Area 
 
Figure 19 represents the effects of 2.0 mM cocaine injection into the pVTA 
on extracellular DA levels in the AcbSh of N, CE, or Ab animals. Injection of 2.0 
mM cocaine into the pVTA increased DA levels within the AcbSh in N animals. In 
contrast, injection of 2.0 mM cocaine into the pVTA of CE or Ab animals reduced 
AcbSh DA levels. For N animals, DA immediately increased to peak levels 20 
min after cocaine injection (161 ± 11% of baseline, p < 0.05) and quickly returned 
to baseline levels 20 min later. For CE animals, DA levels decreased 20 min after 
cocaine injection (75 ± 4% of baseline, p < 0.01) and remained at this level 
throughout 100 min post-injection. While still depressed, DA levels for CE 
animals were not significantly different from baseline at 80 or 100 min after 
cocaine injection (both p-values > 0.07). For Ab animals, DA levels decreased 20 
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min after cocaine injection (76 ± 4%, p < 0.05), reached a minimum level 20 min 
later (6% ± 6%, p < 0.01), then gradually returned to baseline levels at 100 min 
after injection. 
At both 20 min (F(2,17) = 46.4, p < 0.001) and 40 min (F(2,17) = 12.0, p < 
0.001) after 2.0 mM cocaine injection, DA levels were significantly greater for N 
animals compared to both CE and Ab animals (both p-values < 0.005). DA levels 
remained significantly greater for N animals compared to both CE and Ab 
animals (p < 0.05) at 60 min (F(2,17) = 5.8, p < 0.05) after cocaine injection. In 
addition to the time-course analysis, post-injection peak dopaminergic response 
and total AUC were analyzed to succinctly demonstrate the dose-response 
effects of cocaine microinjection in N, CE, and Ab animals. 
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Figure 18. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 1.0 mM cocaine into the pVTA. N: no ethanol-
drinking experience; CE continuous ethanol-drinking experience. + p < 0.05, 
significantly different from baseline levels; # p < 0.05, significantly greater than 
‘CE-1.0’ group. Data are the means ± SEM. 
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Figure 19. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 2.0 mM cocaine into the pVTA. N: no ethanol-
drinking experience; CE: continuous ethanol-drinking experience; Ab: chronic 
ethanol-drinking experience followed by abstinence. + p < 0.05, significantly 
different from baseline levels; # p < 0.05 (Tukey’s b), significantly greater than all 
other groups. Data are the means ± SEM. 
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 Comparison of Maximal Dopaminergic Response 
 
The maximum or minimum peak dopaminergic response compared to 
baseline for each animal was determined. The maximal values were used for 
animals with a net increase in dopaminergic response and minimal values were 
for animals with a net decrease in dopaminergic response. Analysis of the peak 
post-injection percent baseline DA levels revealed significant effects of 
pretreatment (F(2,68) = 10.5, p < 0.001) and dose (F(4,68) = 29.8, p < 0.001) 
along with a ‘pretreatment x dose’ interaction (F(7,68) = 25.6, p < 0.001). 
For N animals, pVTA injection of 0.5 or 1.0 mM cocaine produced greater 
peak AcbSh DA levels compared to injection of 0.25 mM cocaine or aCSF (p< 
0.05). Injection of 2.0 mM cocaine resulted in greater peak DA levels compared 
to injection of aCSF (p< 0.05). For CE animals, injection of 0.25 or 0.5 mM 
cocaine resulted in a significant dose-dependent increase in peak DA levels 
compared to injection of 1.0 or 2.0 mM cocaine or aCSF (p < 0.01). For Ab 
animals, injection of 0.25 mM cocaine resulted in greater peak DA levels 
compared to injection of 0.5 or 2.0 mM cocaine or aCSF (p < 0.001). 
There was no significant effect of pretreatment condition on the peak 
AcbSh DA levels of animals injected with aCSF (F(2,13) = 0.3, p = 0.75). 
Injection of 0.25 mM cocaine resulted in greater peak DA levels in CE and Ab 
animals compared to N animals (p < 0.05). Injection of 0.5 mM cocaine resulted 
in a significant ‘pretreatment’-dependent differences in peak DA levels with CE > 
N > Ab (p < 0.01). Injection of 1.0 mM cocaine produced greater peak DA levels 
for N animals compared to CE animals (p < 0.001). Lastly, injection of 2.0 mM 
cocaine resulted in greater peak DA levels for N animals compared to CE or Ab 
animals (p > 0.001). While comparison of peak DA levels is a useful measure, 
AUC analysis provides a summation of both the magnitude and the shape across 
time of the post-injection dopaminergic response. 
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 Comparison of Area Under the Time-response Curve 
 
Figure 20 represents the AUC values from each group. Briefly, these 
values were calculated as the sum of individual areas (determined via the 
trapezoidal method) between each data point for each individual animal. Analysis 
of the AUC values revealed significant main effects of pretreatment (F(2,68) = 
4.8, p < 0.05) and dose (F(4,68) = 55.2, p < 0.001), as well as a significant effect 
of the ‘pretreatment x dose’ interaction (F(7,68) = 40.1, p < 0.001). For N 
animals, injection of 0.5 or 1.0 mM cocaine into the pVTA resulted in significantly 
greater increases in AUC values compared to injection of 0.25 or 2.0 mM cocaine 
or aCSF (p< 0.05). For CE animals, injection of 0.25 or 0.5 mM cocaine resulted 
in a significant dose-dependent increase in AUC values compared to aCSF 
injection (p < 0.005). On the other hand, injection of 1.0 or 2.0 mM cocaine for 
CE animals resulted in a significant reduction in AUC values compared to 
injection of 0.25 or 0.5 mM cocaine or aCSF (p < 0.05). For Ab animals, injection 
of 0.25 mM cocaine resulted in a significantly greater AUC value compared to 
injection of 0.5 or 2.0 mM cocaine or aCSF (p < 0.001). Conversely, injection of 
2.0 mM cocaine for Ab animals resulted in a significantly smaller AUC value 
compared to aCSF injection (p < 0.01).  
There were no significant differences in AUC values across pretreatment 
of animals injected with aCSF (F(2,13) = 0.2, p = 0.82). Injection of 0.25 mM 
cocaine resulted in a significant ‘pretreatment’-dependent increase of AUC 
values with Ab > CE > N (p < 0.005). Injection of 0.5 mM cocaine resulted in a 
significant ‘pretreatment’-dependent differences of AUC values with CE > N > Ab 
(p < 0.005). Injection of 1.0 mM cocaine resulted in a significantly greater AUC 
value for N animals compared to CE animals (p < 0.001). Lastly, injection of 2.0 
mM cocaine resulted in a significantly greater AUC value for N animals compared 
to CE or Ab animals (p > 0.001). 
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Figure 20. Area under the curve (AUC) analysis for the dose-response effect of 
microinjection of 0-2.0 mM cocaine into the pVTA on DA in the AcbSh following: 
no ethanol-drinking experience (N), continuous ethanol-drinking experience (CE), 
or chronic ethanol-drinking experience followed by a period of protracted 
abstinence (Ab). * p < 0.05 (Tukey’s b), significantly different from aCSF group 
with the same pretreatment. # p < 0.05 (Tukey’s b), significantly greater than ‘N-
0.5’ and ‘N-2.0’ groups. @ p < 0.05 (Tukey’s b), significantly different than all 
other cocaine doses within the same pretreatment. + p < 0.05 (Tukey’s b), 
significant difference between N and CE groups at the same dose of cocaine.   
++ p < 0.05 (Tukey’s b), significant difference between CE and Ab groups at the 
same dose of cocaine. +++ p < 0.05 (Tukey’s b), significant difference between N 
and Ab groups at the same dose of cocaine. Data are the means ± SEM. 
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Figure 21. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 0.5, 1.0, or 2.0 mM cocaine or aCSF into the 
aVTA. N: no ethanol-drinking experience; CE: chronic ethanol-drinking 
experience. Data are the means ± SEM. 
 Nucleus Accumbens Shell Dopaminergic Response After Injection of Cocaine 
into the Anterior Ventral Tegmental Area or Regions Adjacent to the Ventral 
Tegmental Area 
 
Figure 21 represents the effects of microinjections of 0.5 or 2.0 mM 
cocaine or aCSF into the aVTA on extracellular DA levels in the AcbSh of N or 
CE animals, respectively. There were no significant differences in the basal 
extracellular DA levels in the AcbSh resulting from drinking experience  (t(23) = 
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0.7, p = 0.50). Basal DA levels were 1.09 ± 0.09 nM and 1.18 ± 0.08 nM for N 
and CE groups, respectively. There were no significant effects of pretreatment, 
time, dose, or any interaction terms (all F-values < 1.4, all p-values > 0.28).  
Figure 22 represents the effects of 0.25-2.0 mM cocaine or aCSF into 
areas adjacent to the VTA. These injection sites included placements within the 
red nucleus, rostral linear nucleus, interpeduncular nucleus, medial lemniscus, or 
SN. Analysis revealed no significant effects of pretreatment, time, injection site, 
dose, or any interaction terms (all F-values < 2.0, all p-values > 0.16). As such, 
data was collapsed across injection site and dose. There were also six animals 
with injector placements within the pVTA and at least 30% of the microdialysis 
probe area within the dorsal striatum. Basal extracellular DA levels within the 
dorsal striatum for these animals were 4.63 ± 0.45 nM and no significant changes 
in DA levels were observed after cocaine microinjection (F(7,14) = 0.4, p = 0.64). 
 
 
Figure 22. Time course of extracellular DA levels in the AcbSh of P rats before 
and after the microinjection of 0.5, 1.0, or 2.0 mM cocaine or aCSF into areas 
adjacent to the VTA. N: no ethanol-drinking experience; CE: continuous ethanol-
drinking experience; Ab: chronic ethanol-drinking experience followed by a period 
of protracted abstinence. Data are the means ± SEM. 
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4. DISCUSSION 
 Sensitization of Cocaine Reinforcement within the Nucleus Accumbens Shell 
Following Chronic Ethanol Drinking 
   
The results of the experiment indicate: (1) adult P rats initiated and 
maintained the self-infusion of cocaine into the AcbSh, but not the AcbC (Figures 
3 and 12); and (2) voluntarily consumption of significant amounts of ethanol 
under continuous conditions, compared to water access only, reduced the 
threshold dose for self-infusion of cocaine and produced greater increases in 
responding for cocaine after a drug-free period (Figures 3, 6, 10, and 11). The 
results confirm the AcbSh as a critical brain site mediating the initiation of 
cocaine reinforcement and support the hypothesis that chronic continuous 
ethanol-drinking experience increases the sensitivity of the AcbSh to the 
reinforcing effects of cocaine. 
 Cocaine Reinforcement within the Nucleus Accumbens Shell 
 
 The present study is in agreement with previous research finding both 
outbred Wistar and selectively-bred P rats, as well as mice, will self-administer 
physiologically relevant concentrations of cocaine into the AcbSh, but not the 
AcbC (David et al., 2001; Katner et al., 2011; McKinzie et al., 1999; Rodd-
Henricks et al., 2002a). Ethanol-naïve P rats reliably self-infused concentrations 
of 2.0, 4.0, and 8.0 mM cocaine (200-800 pmol / infusion) into the AcbSh, but did 
not self-infuse cocaine at any concentration into the AcbC (Figures 3, 6, 12). P 
rats in the current study reliably self-infused cocaine into the AcbSh at the same 
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range of concentrations (2.0-8.0 mM) as previous experiments with P rats self-
infusing cocaine into the AcbSh (Katner et al., 2011). Neither the current study 
nor Katner et al. (2011) examined the descending limb of the dose-response 
curve (> 8.0 mM cocaine) for the self-infusion of cocaine into the AcbSh of P rats. 
However, the self-infusion of cocaine into the AcbSh or pVTA of Wistar rats 
(Rodd-Henricks et al., 2002a; Rodd et al., 2005a) exhibited an inverted-U-shaped 
dose-response curve.  
Doses supporting self-infusion in the current study correspond well with 
the amount of locally delivered cocaine required to increase DA and serotonin 
levels within the Acb, elicit locomotor activation, or produce a CPP (Andrews and 
Lucki, 2001; Delfs et al., 1990; Filip and Siwanowicz, 2001; Ikemoto, 2002; 
Teneud et al., 1996). The discrimination of the active from the inactive lever 
during Sessions 1-4 and Session 8 suggests the self-infusion of 2.0-8.0 mM 
cocaine into the AcbSh is not the result of an increase in general locomotor 
activity (Figure 11; Ikemoto and Wise, 2004). Lever discrimination is relevant 
because microinjection of cocaine or mixtures of D1 and D2 receptor agonists into 
the AcbSh, but not AcbC, elicited significant locomotion and rearing (Choi et al., 
2000; Filip and Siwanowicz, 2001; Ikemoto, 2002). Additionally, sodium channel 
inhibition did not play a significant role in cocaine’s neurochemical or reinforcing 
effects within the AcbSh (Hernandez et al., 1991; Ikemoto, 2003).  
Lack of reliable cocaine self-infusion into the AcbC or areas ventral to the 
AcbSh (see Figures 12 and 13) confirms the findings of Rodd-Henricks et al. 
(2002a). Anatomical controls are critical for mapping the boundaries of a drug’s 
local site of action. Concerns of anatomical specificity arise due to the unknown 
extent of drug diffusion away from the injection site and the tendency for drug 
efflux up the cannula shaft due to differential pressure (Ikemoto and Wise, 2004; 
Wise and Hoffman, 1992). Previous studies using the same or a similar drug-
delivery system as the current experiments show a similar neuroanatomical 
specificity (AcbSh but not AcbC) for other drugs of abuse (Engleman et al., 2009, 
Hoebel et al., 1983; Ikemoto et al., 2005; Olds, 1982; Rodd et al., 2003b). 
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Diffusion away from injection site did not appear to contribute to the observed 
self-infusion behaviors in the current experiment, given the use of small injection 
volumes and the range of cocaine concentrations tested. The functional 
properties of DAT differ between the AcbSh and AcbC, corresponding to the 
increased sensitivity to the effects of psychostimulants of the AcbSh compared to 
the AcbC (David et al., 1998). The AcbSh, but not the AcbC, contained potential 
sites on the DAT for functional interactions between DA and norepinephrine 
(Nirenberg et al., 1997). The AcbSh also exhibited more transient DA release 
relative to the AcbC, associated with less efficient DA uptake in this subregion 
(Jones et al., 1996).  
The direct effects of cocaine within the Acb are likely mediated via its 
actions as a non-specific monoamine reuptake inhibitor (Reith et al., 1986; Ritz et 
al., 1987), as local application produced significant increases in DA, serotonin, 
and norepinephrine (Andrews and Lucki, 2001; Hernandez et al., 1991; Li et al., 
1996; Teneud et al., 1996). Cocaine-evoked increases serotonin and 
norepinephrine also potentially modulate the effects of DA within the Acb (Filip et 
al., 2005; Li et al., 1996; Smith and Aston-Jones, 2008), and serotonin can act 
locally to increase DA release (Campbell and McBride, 1995; Chen et al., 1991; 
Parsons and Justice, 1993; White, 1990). Cocaine’s ability to increase DA levels 
in the Acb results in the activation of local D1 and D2 receptors. The cooperative 
activation of D1 and D2 receptors in the Acb (Clark and White, 1987) appears to 
be essential in the reinforcing actions of stimulants within the Acb (Ikemoto et al., 
1997a), as well as cocaine sensitization (Henry et al., 1998). 
Another significant finding from the current study is the increased level of 
active lever responding and self-infusions of N rats at ‘optimal concentrations’ 
after cocaine access was restored in Session 8. N rats obtained more infusions 
of 2.0 or 4.0 mM cocaine during Session 8 compared to the final session before 
extinction (Session 4; Figure 7). Furthermore, rats self-infusing a marginally 
reinforcing concentration (1.0 mM) did not display lever discrimination during the 
initial four sessions, but produced clear lever discrimination and a significant 
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number of self-infusions during Session 8 (Figures 6 and 10). Previous ICSA 
studies with ethanol-naïve P rats found robust increases in active lever 
responding and infusions after previous access to either ethanol or cocaine was 
restored (Katner et al., 2011; Rodd et al., 2004a, 2005b,c). Moreover, P rats 
receiving ethanol access for seven consecutive sessions did not show this effect 
by the final session (Rodd et al., 2005d), suggesting potentiated responding 
resulted from neuronal alterations within the AcbSh or afferent and efferent 
connections occurring during the drug-free period. A number of molecular, 
neurochemical, and behavioral adaptations appear to contribute to the 
sensitization of cocaine reinforcement and locomotor response (Nestler, 2001; 
Self, 2004; Wolf, 2010). For example, rats exhibited increased breakpoints for 
cocaine IVSA only after 10 d of discrete trial self-administration followed by 7 d of 
deprivation, but not with continuous access to cocaine or shorter periods of 
deprivation (Morgan and Roberts, 2004). On the other hand, the observed effects 
could reflect tolerance to cocaine’s neurochemical effects within the Acb. Rats 
were potentially compensating for lower basal levels of DA in the Acb by self-
infusing greater amounts of cocaine, as 1-2 wk of contingent or non-contingent 
cocaine injections produced transient decreases in basal Acb DA levels 3-10 d 
after the final exposure (Meil et al., 1995; Rossetti et al., 1992).   
Genetic factors potentially meditated the increased responding for cocaine 
during Session 8, as outbred Wistar rats generally do not show increased active 
lever responding and self-infusions after ethanol or cocaine access is restored 
(Rodd et al., 2004a,b; Rodd-Henricks et al., 2002a, 2003). Supporting this idea, 
animals with high novelty seeking and sensitivity to drugs of abuse (HR) showed 
an ‘up-ward’ shift of the dose-response curve of IVSA cocaine compared to low 
novelty-seeking (LR) animals which was associated with an increased maximal 
response to cocaine (Piazza et al., 2000). Rats selectively bred for alcohol 
preference, compared to alcohol-non-preferring and outbred rat strains, 
displayed an increased sensitivity to the reinforcing and neurochemical effects of 
cocaine (Honkanen et al., 1999; Katner et al., 2011; Le et al., 2006; Leggio et al., 
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2003; Marttila et al., 2007; Mikkola et al., 2001; 2002). Thus, selective breeding 
for alcohol preference potentially produced a phenotype associated with a more 
general preference for drugs of abuse. Alcohol-preferring rats are innately 
different from non-preferring and outbred rat strains when examining basal 
neurotransmitter levels, receptor expression, and pharmacological 
responsiveness in limbic brain regions (Bell et al., 2006a; McBride and Li, 1998; 
Murphy et al., 2002). 
 Effects of Continuous Ethanol Experience 
 
Following continuous, ethanol-drinking experience, P rats displayed an 
increased sensitivity to the reinforcing effects of cocaine within the AcbSh relative 
to their ethanol-naïve counterparts. The observation of leftward shift in the dose-
response curve for active lever responding and infusions during the acquisition of 
cocaine ICSA under a FR1 schedule supports this concept. The results of this 
study are congruent with previous work finding P rats with the same protocol of 
chronic continuous ethanol drinking displayed an increased sensitivity to the 
reinforcing effects of ethanol within the pVTA (Rodd et al., 2005b,c). CE animals 
reliably self-infusing a concentration of cocaine (0.5 mM) not self-infused by N 
animals (Figures 3 and 10), also supports the interpretation of an increased 
sensitivity to cocaine’s reinforcing effects. Lastly, CE reliably self-infused 1.0 mM 
cocaine, whereas this concentration was only marginally reinforcing for N 
animals (Figure 3).  
The enhanced sensitivity of the AcbSh to the reinforcing effects of cocaine 
in CE rats compared to N rats was not likely a result of the presence of 
appreciable ethanol levels within the brain or plasma, as access to the 15% 
ethanol solution was removed 4 h before the beginning of each ICSA session. 
Adult P rats receiving unlimited free-choice access to 10% ethanol drank 5-8 
g/kg/d and showed peak blood ethanol levels of 60-120 mg% during the dark 
cycle, with an average content of 55 mg% at the end of the dark cycle (Bell et al., 
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2006b; Murphy et al., 1986). Four h after the removal of ethanol access, 
increased peripheral and central ethanol levels resulting from consumption 
should have diminished to negligible levels (Engleman et al., 2008; Robinson et 
al., 2000; Yim et al., 2000). Indeed, removal of ethanol bottles 3 h before the 
beginning of microdialysis produced no detectable levels of ethanol within the 
VTA extracellular milieu during the first baseline sample (Engleman et al., 2011). 
On the other hand, P rats potentially underwent acute withdrawal and were 
responding for lower concentrations of cocaine and self-administering more 
infusions to partially counteract the local withdrawal effects. This is unlikely 
though, as CE rats in the current study displayed higher overall levels of infusion 
only during reinstatement and not during acquisition. Nevertheless, P rats given 6 
wk of unlimited access to 10% ethanol voluntarily consumed more than 5 g/kg/d 
and displayed signs of physical dependence (Kampov-Polevoy et al., 2000), but 
more robust signs of withdrawal was not observed until after 20 wk of ethanol 
drinking (Waller et al., 1982). Additionally, animals were habituated to the 
removal of ethanol access 4 h before the ICSA experimental session, preventing 
or attenuating withdrawal symptoms by eliminating the unexpected removal of 
ethanol access. 
Similar to the current study, outbred Wistar rats with high ethanol intakes 
were more sensitive to cocaine-induced locomotion and CPP than rats with low 
ethanol intake (Stromberg and Mackler, 2005). Mice receiving 7 d of repeated 
ethanol injections displayed a CPP for cocaine associated with enhanced 
synaptic plasticity of NMDA receptors on VTA DA neurons (Bernier et al., 2011). 
Furthermore, high levels of operant lever responding for oral ethanol predicted a 
more rapid acquisition of lever responding for IVSA cocaine compared to lower 
levels of ethanol responding (Mierzejewski et al., 2003). Repeated systemic 
ethanol treatments produced an enhanced locomotor response to a subsequent 
injection of cocaine, which was associated with a long-term enhancement of 
evoked DA and ACh release in the Acb (Nestby et al., 1997) and an increased 
number of striatal DAT binding sites (Itzhak and Martin, 1999). Additionally, local 
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application of cocaine produced a greater increase in Acb DA levels for animals 
with ethanol-drinking experience compared to naïve controls (Yoshimoto et al., 
2000). Chronic ethanol exposure also abolished the subsequent conditioned 
taste aversion to cocaine seen in ethanol-naïve animals, suggesting ethanol 
exposure may reduce the aversive effects of subsequent cocaine exposure 
(Kunin et al., 1999; Grakalic and Riley, 2002).  
Another important finding is the observation of more pronounced 
differences in active lever responding and self-infusions of CE rats compared to 
N rats after cocaine access was restored in Session 8. In the current study, CE 
rats responded more on the active lever for and obtained more infusions of 0.5, 
1.0, 2.0, or 4.0 mM cocaine during Session 8 compared N rats and compared to 
Session 4 (Figures 7, 10, 11). Previous studies observed similar effects of 
ethanol-drinking experience on subsequent ethanol self-infusion into the pVTA of 
P rats (Rodd et al., 2005b,c). The increased rates of responding and infusion 
during Session 8 in CE rats may be due to a tolerance and not a sensitization to 
the reinforcing effects of cocaine, requiring animals to infuse more cocaine to 
obtain the same effect. This is unlikely, as a decrease in the threshold 
concentration for self-infusion during acquisition and reinstatement accompanied 
the ‘up-ward’ shift seen during Session 8. Similar to (Rodd et al., 2005c), self-
administration of the highest drug concentration did not produce higher levels of 
active lever responding or infusions during Session 8 for CE rats relative to the 
ethanol-naïve counterparts. This finding suggests against a ‘right-shift’ in the 
curve associated with rate tolerance (Zernig et al., 2004). CE rats displayed 
larger increases in active lever responding and infusions during Session 8 
compared to N controls. Thus, chronic ethanol drinking exacerbated the effects a 
drug-free period on cocaine reinforcement, potentially related to a further 
dysregulation of neurotransmitter release, uptake, and postsynaptic action. 
During sessions where aCSF was substituted for cocaine (Sessions 5-7), 
the 2.0 mM group of N rats and the 2.0 and 4.0 mM groups of CE rats displayed 
a diminished extinction of responding for cocaine relative to the other groups 
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(Figures 10 and 11). During Sessions 5 and 7, N rats originally receiving 2.0 mM 
cocaine increased responding on the inactive lever (Figure 11). Rats initially self-
infusing an ‘optimal’ concentration of ethanol (125-150 mg%) also increased 
inactive lever responding during the first extinction session (Rodd et al., 2004a,b; 
2005b,c). The higher inactive lever responding during extinction may reflect 
enhanced cocaine-seeking behavior resulting from a concentration of 2.0 mM 
producing the highest level of conditioned cue reactivity. In the current study, as 
with a number of other ICSA experiments, a cue light above the active lever was 
illuminated during all of the sessions, regardless of drug availability. Indeed, 
discriminative stimuli predicting IVSA cocaine access are particularly resistant to 
extinction and can induce lever responding even after extended periods of 
abstinence (Weiss et al., 2001). 
Putative mechanisms mediating the increased sensitivity of the AcbSh to 
the reinforcing effects of cocaine produced by long-term ethanol exposure are 
unknown, but research suggests a role for alterations in the function of 
monoamine transporters and a number of neurotransmitter receptors. For 
example, long-term (e.g. at least 8 wk) continuous free-access ethanol drinking 
by animals selectively bred for high ethanol consumption produced a general up-
regulation in basal and evoked dopaminergic neurotransmission within the Acb. 
This was indicated by: increased basal DA levels (Thielen et al., 2004), 
decreased D2 autoreceptor function (Engleman et al., 2003), accelerated basal 
DA uptake (Carroll et al., 2006), and increased responsiveness to DAT-inhibited 
DA increases (Engleman et al., 2000), without alterations in the number of DA 
terminals (Zhou et al., 2006). The most evident substrate for changes in cocaine 
reinforcement within the AcbSh is the DAT. While cocaine binds to NET, SERT, 
and DAT (Ravna et al., 2009; Reith et al., 1986; Ritz et al., 1990), the potency for 
cocaine reinforcement is most strongly correlated with the affinity at the DAT 
(Ritz et al., 1987). On the other hand, studies with genetic knockout animals 
suggest both SERT and DAT play an important role in cocaine reinforcement 
(Filip et al., 2005; Hall et al., 2004; Sora et al., 2001; but see Chen et al., 2006).  
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Because kinetic and binding experiments were not performed in the 
current study, it is unclear if the potential up-regulation of cocaine-mediated DAT 
inhibition after ethanol exposure would result from an increased number of DAT 
binding sites for cocaine, an increased efficacy of cocaine to inhibit DAT, or an 
increased affinity of DAT for cocaine. For example, the up-regulation of Acb DA 
uptake inhibition by a selective DAT inhibitor after ethanol drinking (Engleman et 
al., 2000) is associated with a down-regulation of Acb D2 autoreceptors, but not 
an increased level of DA clearance under basal conditions (Engleman et al., 
2003; Thielen et al., 2004). Changes in DA uptake are likely a compensatory 
response to increased dopaminergic signaling as repeated ethanol exposure 
produces the accumulation of DA in the extracellular area (Grace, 2000; Thielen 
et al., 2004), and acute ethanol did not alter DA uptake in the Acb (Budygin et al., 
2001; Jones et al., 2006). On the other hand, physiologically relevant 
concentrations of ethanol directly affected DAT function (Mayfield et al., 2001; 
Zahniser et al., 1999). Changes in DA uptake also potentially resulted from 
alterations in presynaptic D2 autoreceptor function, however the specific 
mechanisms remain unclear (Mayfield and Zahniser, 2001; Schmitz et al., 2002). 
Increases in cocaine reinforcement could also be promoted by an ethanol-
induced enhanced sensitivity of postsynaptic D1 receptors and subsensitivity of 
presynaptic D2 autoreceptors within the AcbSh. Chronic ethanol drinking (free 
access or liquid diet) by outbred rats produced an up-regulation of Acb D1 
receptors (Bailey et al., 2001; May, 1992). However, both studies showed no 
alterations in the number of D1 receptor binding sites, analogous to findings with 
chronic stimulant treatment (White and Kalivas, 1998). In addition to the in vivo 
microdialysis experiments using alcohol-preferring rats (Engleman et al., 2003; 
Thielen et al., 2004), binding studies using outbred rats also found evidence of 
D2 receptor down-regulation within the Acb (Rommelspacher et al., 1992; 
Syvalahti et al., 1988). Moreover, human alcoholics displayed reduced D2 binding 
in a number of brain regions (Volkow et al., 1996). Chronic ethanol drinking by 
inbred P rats produced intakes of 10 g/kg/d resulting in increased D1 and D2 
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receptor density within rostral regions of the AcbSh and AcbC (Sari et al., 2006). 
Because D2 receptors are located both pre- and postsynaptically within the Acb 
(Pickel et al., 2006; Sesack et al., 1994), in vitro changes are difficult to interpret. 
 Lastly, ethanol-induced changes in AcbSh cocaine reinforcement may have 
resulted from an up-regulation of local D3 receptors. Long-term (1 y) continuous 
ethanol drinking by both P and HAD rats produced increased striatal expression 
of D3 receptors (Vengeliene et al., 2006), while D3 receptor blockade within the 
AcbSh attenuated cocaine sensitization (Ramiro-Fuentes and Fernandez-Espejo, 
2010).  
The observed changes in cocaine reinforcement within the AcbSh are 
potentially partially mediated by an up-regulation of SERT function and down-
regulation of 5-HT3 receptor function within the AcbSh. Cocaine shows a higher 
affinity for SERT than DAT (Matecka et al., 1996; Ritz and Kuhar, 1989; Ritz et 
al., 1990) and is more potent at SERT- compared to DAT- and NET-inhibition 
within the Acb (Uchimura and North, 1990). Serotonin acts within the Acb at 5-
HT3 receptors to release DA locally (Campbell and McBride, 1995; Chen et al., 
1991; Parsons and Justice, 1993; but see Campbell et al., 1995; Li et al., 1996). 
Ethanol positively modulates 5-HT3 receptor function (Lovinger, 1999; Lovinger 
and Zhou, 1998; Sung et al., 2000), while cocaine binds to the 5-HT3 receptor to 
inhibit ion conductance (Breitinger et al., 2001; Carta et al., 2003). The induction 
of cocaine sensitization resulted in a down-regulation of 5-HT3 receptor 
immunoreactivity within the AcbSh, but not the AcbC (Ricci et al., 2004). 
Systemic injections of a 5-HT3 receptor antagonist attenuated cocaine-induced 
CPP, locomotor activity, and Acb DA release (Kankaanpaa et al., 2002). Chronic 
ethanol treatment increased SERT mRNA within the Acb (Shibasaki et al., 2010), 
while P rats with chronic ethanol-drinking experience attenuated increases in Acb 
DA levels evoked by local 5-HT3 receptor activation (Thielen et al., 2004; but see 
Yoshimoto et al., 1996). 
Overall, the present results confirm the AcbSh as an important brain 
region mediating the acquisition of cocaine reinforcement and support the 
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hypothesis that a prolonged period of ethanol drinking increases the sensitivity to 
the reinforcing effects of cocaine within the AcbSh. Chronic ethanol drinking 
putatively produces neuronal alterations within the terminal region of 
mesoaccumbens brain circuitry, rendering an individual more sensitive to the 
reinforcing effects of cocaine and thus more susceptible to acquiring cocaine 
self-administration.  
 Persistent Alteration of Posterior Ventral Tegmental Area Dopamine Neurons to 
the Stimulating Effects of Cocaine Following Chronic Ethanol Drinking 
 
The results of the experiment indicate: (1) administration of cocaine into 
the pVTA, but not the aVTA, increased extracellular DA levels in the AcbSh of 
adult P rats (Figures 16-19 and 21); (2) voluntarily consumption of ethanol under 
continuous conditions, compared to water access only, reduced the threshold 
dose of cocaine needed to increase DA levels, produced greater DA release at a 
moderate dose of cocaine, and resulted in decreased DA levels at high doses of 
cocaine (Figures 16-20); and (3) the altered response of pVTA DA neurons to 
cocaine was further augmented 30 d after termination of ethanol drinking 
(Figures 16-20). These results demonstrate a local activating effect of cocaine on 
pVTA DA neurons and support the hypothesis that chronic continuous ethanol-
drinking experience induces persistent alterations in the sensitivity of pVTA DA 
neurons to the stimulating actions of cocaine. 
 Stimulating Effects of Cocaine on Posterior Ventral Tegmental Area Dopamine 
Neurons 
 
The present study appears to be the first demonstrating transient 
increases in extracellular levels of DA within the AcbSh following pulsed 
microinjections of cocaine directly into the pVTA, at doses supporting local self-
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administration (Rodd et al., 2005a). Injections of 0.5 or 1.0 mM (1.5 nmol or 3.0 
nmol total) cocaine into the pVTA produced robust increases in AcbSh DA levels 
(160-170% baseline), while injections of 0.25 or 2.0 mM (0.75 nmol or 6.0 nmol) 
cocaine produced smaller and more transient increases in DA levels (130-160% 
baseline). The current results confirm previous research finding outbred Wistar 
rats reliably self-administered 0.5-2.0 mM, but not 0.25 or 4.0 mM, cocaine into 
the pVTA (Rodd et al., 2005a). Animals received 30 microinjections of cocaine 
over a 10-min period, however DA levels remained elevated for 20-60 minutes. A 
peripheral injection of a high dose of cocaine (15 mg/kg) has been shown to 
produce a similar time course and maximal effect in Acb DA levels (Kalivas and 
Duffy, 1991, 1993). The ICSA of cocaine into the pVTA of P rats has not yet been 
examined, but the lack of significant DA-stimulating effect at 2.0 mM potentially 
resulted from P rats having a relatively greater sensitivity to cocaine within the 
pVTA compared to Wistar rats (e.g. leftward-shift in the dose-response curve). 
Supporting this, P rats were more sensitive to the reinforcing effects of cocaine or 
ethanol within the AcbSh and ethanol within the pVTA (Engleman et al., 2009; 
Katner et al., 2011; Rodd et al., 2004a). Concentrations greater than 2.0 mM 
were not examined in the current study, and it remains unclear if higher doses 
would produce decreases in Acb DA. This effect is plausible, given the putative 
mechanisms of cocaine within the VTA and the effects of pVTA cocaine following 
chronic continuous ethanol drinking.  
Other experiments with intra-VTA infusion of cocaine also support the 
current findings regarding the stimulating effect of cocaine on pVTA neurons. For 
example, mice learned to self-infuse 0.6 or 3.0 mM cocaine into the pVTA (David 
et al., 2004). Moreover, daily bilateral intra-pVTA injections of 5-nmol cocaine for 
4 d produced behavioral sensitization to a systemic cocaine challenge (Cornish 
and Kalivas, 2001). On the other hand, Initial in vivo studies suggested local 
effects of cocaine within the VTA partially and transiently inhibited most, but not 
all, DA neurons (Einhorn et al., 1988). However, these results were likely 
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complicated by chloral hydrate anesthesia inhibiting GABA neuronal activity (Lee 
et al., 2001; Steffensen et al., 2008).  
In contrast to the pVTA, microinjections of cocaine into the aVTA did not 
alter DA levels in the AcbSh at any dose tested (Figure 21). Moreover, injections 
of cocaine into areas adjacent to the VTA also failed to alter DA levels in the 
AcbSh (Figure 22). Thus, the observed effects after microinjection of cocaine into 
pVTA were not due to diffusion of cocaine into the aVTA or areas surrounding 
the VTA. Also supporting this finding, cocaine is not self-administered into the 
aVTA (Rodd et al., 2005a). Regional differences within the VTA with regard to 
afferent innervation, synaptic connectivity, and relative receptor location and 
function appear to produce the functionally heterogeneous effects. Activation of 
GABAA receptors in the aVTA, but not the pVTA, increased the reinforcing effects 
of IVSA cocaine on a progressive ratio (PR) schedule (Lee et al., 2007). DA 
neurons within the pVTA, relative to the aVTA, are under greater D2-mediated 
tonic inhibition while DA neurons within the aVTA appeared to be under greater 
GABAA-mediated tonic inhibition (Ding et al., 2009b). Lastly, receptors for ORX 
exist on DA neurons in the pVTA projecting to the medial PFC and AcbSh, but 
not on neurons in the aVTA innervating the AcbC (Vittoz et al., 2008).  
The mechanisms through which microinjections of cocaine into the pVTA 
produce increases in extracellular DA within the AcbSh are not completely clear, 
but a number of recent studies elucidated putative substrates. Cocaine’s actions 
as a non-specific monoamine reuptake inhibitor (Reith et al., 1986) likely mediate 
the direct effects of cocaine within the pVTA. Local application of cocaine 
produced significant increases in VTA DA, serotonin, and norepinephrine (Chen 
and Reith, 1994a,b). On the other hand, increased VTA DA neuronal activity due 
to direct interaction between cocaine and 5-HT3 or nicotinic ACh receptors on DA 
neurons is unlikely, as cocaine binding inhibited conductance of these ion 
channels (Breitinger et al., 2001; Carta et al., 2003; Hess et al., 2000; Ulrich et 
al., 1998). At concentrations equivalent to the current study, cocaine showed a 
higher affinity for SERT than DAT and was more potent inhibiting serotonin 
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versus DA uptake (Matecka et al., 1996; Ritz et al., 1990; Uchimura and North, 
1990). Cocaine-induced increases in VTA serotonin levels activated 5-HT2A 
receptors (McMahon and Cunningham, 2001) located on VTA DA neurons 
(Doherty and Pickel, 2000) to increase DA neuronal firing (Pessia et al., 1994; 
Prisco et al., 1994). Cocaine acted indirectly through serotonin to: activate 5-
HT1B receptors (O’Dell and Parsons, 2004) located presynaptically on GABA 
terminals (Sari et al., 1999), decrease GABA release (Johnson and North, 1992), 
reduce GABA-B-receptor-evoked inhibitory postsynaptic potentials in DA neurons 
(Cameron and Williams, 1994), and ultimately increase DA neuronal firing (Guan 
and McBride, 1989; Yan and Yan, 2001). 
The indirect mechanisms by which acutely administered cocaine into the 
pVTA produced transient increases in AcbSh DA may also include glutamatergic 
and noradrenergic influences. Cocaine-induced increases in VTA DA levels 
activate presynaptic D1 receptors to increase local glutamate levels (Kalivas and 
Duffy, 1995). Furthermore, the application of cocaine to VTA DA neurons 
increased the magnitude of NMDA excitatory postsynaptic currents (Schilstrom et 
al., 2006), which leads to increase VTA DA neuron burst firing (Canavier and 
Landry, 2006). Supporting this idea, selective NMDA blockade within the VTA 
eliminated both the tonic and phasic cocaine-induced DA increases within the 
AcbSh (Aragona et al., 2008; Sombers et al., 2009). Cocaine-induced increases 
in VTA norepinephrine increased DA neuronal excitability (Grenhoff et al., 1995) 
via actions at alpha-1 adrenergic receptors located on a subset of VTA DA 
neurons (Bayer and Picker, 1990). At higher doses of cocaine, significant binding 
to DAT produces increased levels of DA in the VTA, leading to DA neuronal 
inhibition. In this case, DA neurons are inhibited by activation of D2 autoreceptors 
located on DA perikarya and dendrites to directly inhibit DA firing (White and 
Wang, 1984). At much higher concentrations, cocaine reduced tonic inhibition of 
pVTA DA neurons by acting presynaptically to block voltage-sensitive sodium ion 
channels on local GABA neurons (Steffensen et al., 2008). However, the doses 
of cocaine used in the current experiment correspond to concentrations much 
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lower than concentrations used in Steffensen et al. (2008). The relative 
contribution of afferent inputs, including the magnitude and temporal pattern of 
direct and indirect feedback/feedforward loops from the Acb to the VTA (Sesack 
and Grace, 2010; Xia et al., 2011), also affected the profile of AcbSh DA after 
pVTA cocaine injection.  
 Effects of Continuous Ethanol Experience 
 
Following continuous, free-choice ethanol-drinking experience, P rats 
displayed an augmentation in the sensitivity of pVTA DA neurons to the 
stimulating actions of cocaine relative to their ethanol-naïve counterparts. 
Chronic ethanol-drinking experience reduced the threshold dose of cocaine 
needed to increase DA levels, produced greater DA release at a moderate dose 
of cocaine, and resulted in decreased DA levels at high doses of cocaine. 
Generally, the data represent a leftward shift in the dose-response curve (Figure 
20), although DA neuronal inhibition at concentrations higher than 2.0 mM 
cocaine was not confirmed in ethanol-naïve animals. Injections of 0.25 or 0.5 mM 
cocaine into the pVTA produced robust increases in AcbSh DA levels (200 and 
320% baseline, respectively), while injections of 1.0 or 2.0 mM cocaine produced 
robust decreases in DA levels (70-75% baseline). The observed increase in 
maximal response to 0.5 mM cocaine suggests a sensitization to the DA-
neuronal-stimulating effects because higher cocaine concentrations produced a 
decreased maximal response. Unfortunately, corroborating data from an ICSA 
study examining the effects of chronic continuous ethanol drinking on the self-
administration of cocaine into the pVTA is not available, as the experiments are 
ongoing. However, preliminary results suggest a similar finding as the current 
microinjection-microdialysis study (unpublished observations).  
Moreover, the results are in agreement with a number of previous findings. 
First, chronic continuous ethanol drinking produced functional alterations in P 
rats, resulting in an increased sensitivity to the reinforcing effects of intra-AcbSh 
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cocaine (current study). Second, ethanol-experienced (3 g/kg/d intake), but not 
ethanol-naïve, Wistar rats displayed increased levels of DA in AcbSh after pVTA 
injections of 100 mg% ethanol (Rodd et al., 2006a). Lastly, P rats receiving the 
same protocol of chronic ethanol drinking as the current experiment displayed an 
increased sensitivity to the reinforcing effects of ethanol within the pVTA (Rodd et 
al., 2005b), as evidenced by an upward and leftward shift in the dose-response 
curve (Zernig et al., 2004).  The enhanced sensitivity of the pVTA to the 
stimulating and inhibitory effects of cocaine in CE rats compared to N rats was 
not likely a result of the presence of appreciable ethanol levels within the brain or 
plasma, as access to the 15% ethanol solution was removed 4 h before the 
beginning of the microdialysis experiment.  
Similar to experiments examining DA functioning in the Acb, P rats with 
long-term, voluntary ethanol-drinking experience exhibited an increased number 
of spontaneously active VTA DA neurons (Morzorati et al., 2010), Moreover, 
chronic ethanol drinking produced decreased pVTA DA levels along with 
increased DA clearance (Engleman et al., 2011). Divergent findings from other 
research underscore the importance of factors such as genetic background and 
voluntary drinking. Repeated ethanol injections (which often produce 
dependency) in outbred animals produced a hypodopaminergic state, including 
fewer spontaneous active VTA DA neurons (Shen et al., 2007), decreased firing 
rates (Diana et al., 1992, 1995, 1996), and decreased Acb DA levels (Diana et 
al., 2003; Rossetti et al., 1992; Weiss et al., 1996).  
At low to moderate doses, cocaine injections into the pVTA produced 
increased levels of DA neuronal activity in ethanol-drinking animals compared to 
ethanol-naïve animals. Increased cocaine-evoked neuronal activity potentially 
resulted from an increased excitatory tone, decreased inhibitory tone, or 
alterations in serotonergic function. Chronic ethanol drinking or a single ethanol 
injection (Saal et al., 2003; Stuber et al., 2008) induced LTP of AMPA functioning 
in the VTA by enhancement of glutamatergic afferent input through the 
stimulation of the D1 receptor (Deng et al., 2009; Xiao et al., 2009). AMPA LTP 
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enhanced tonic DA levels within terminal regions (Grace et al., 2007), and 
strengthened activity-dependent synaptic plasticity (Wolf et al., 2004). In a 
complementary manner, repeated ethanol injections induced NMDA LTP (Bernier 
et al., 2011), increasing the probability of DA neuronal burst firing.  
Ethanol induction of NMDA and AMPA LTP is consistent with the 
increased expression of the NMDAR1 and GluR1 ionotropic glutamate receptor 
subunits within the VTA after chronic ethanol drinking (Ortiz et al., 1995). 
Moreover, pVTA DA neurons were more sensitive to in vivo NMDA-elicited burst 
firing in P rats with 8 wk of continuous ethanol drinking than in ethanol-naïve 
controls (Fitzgerald and Morzorati, 2010). Acute ethanol treatment impaired LTP 
induction at GABA synapses onto VTA DA neurons (Guan and Ye, 2010; but see 
Melis et al., 2002), and GABA inhibition can potently suppress NMDA-induced 
burst firing (Lobb et al., 2010). Overall, ethanol drinking potentially produced an 
enhancement of NMDA LTP and an impairment of GABA LTP promoting robust 
neuronal excitability of VTA DA neurons during cocaine treatment. Chronic 
ethanol drinking could also increase the stimulating effects of lower 
concentrations of cocaine via an up-regulation of cocaine-evoked serotonin 
uptake inhibition. Ethanol-induced adaptations in VTA SERT function are tenable 
because repeated ethanol treatment increased transporter expression in the Acb, 
cortex, and hippocampus (Shibasaki et al., 2010).  
At high doses, cocaine injections into the pVTA produced decreased 
levels of DA neuronal activity in ethanol-drinking animals compared to both 
baseline levels and ethanol-naïve animals. Decreased cocaine-evoked neuronal 
activity potentially resulted from an up-regulation of: cocaine-evoked DAT 
inhibition, D2 autoreceptor function, or GABAergic inhibition. For example, 
ethanol-induced alterations in DAT functioning within the VTA could increase the 
effectiveness of cocaine to inhibit the somatodendritic uptake of DA in a manner 
similar to the observed effect in the Acb (Yoshimoto et al., 2000). Supporting this 
concept, voluntary ethanol drinking by Wistar rats resulted in increased DAT 
binding within the VTA (Jiao et al., 2006). Repeated ethanol injections produced 
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a supersensitivity of D2 autoreceptors on VTA DA neurons to inhibit neuronal 
firing (Perra et al., 2011). This was observed as an enhancement in both the 
magnitude and duration of neuronal inhibition, which resulted from a down-
regulation of the calcium-dependent ‘desensitization-cascade’ of inositol 1,4,5-
triphosphate and calcium/calmodulin-dependent protein kinase II. While acute 
ethanol activates the cAMP-protein kinase A (PKA) cascade via actions at D1 
receptors and/or AC, chronic ethanol exposure produces a down-regulation of 
cAMP-PKA activity and alters CREB functioning in a number of mesolimbic brain 
regions (Pandey, 2004; Ron and Jurd, 2005).  
Genetic factors may affect ethanol-induced adaptations in D2 receptor 
functioning within the VTA, as P rats displayed 25% less D2 receptor binding in 
this region compared to NP rats (McBride et al., 1993). Increased inhibitory tone 
could also contribute to the observed decrease in cocaine-evoked neuronal 
activity, as chronic ethanol treatment increased VTA GABA neuronal firing and 
GABA release onto VTA DA neurons (Gallegos et al., 1999; Melis et al., 2002). 
Decreased GABAA-inhibition potentially contributed to increased VTA GABA 
neuronal activity, as chronic ethanol drinking produced decreased expression of 
the VTA GABAA alpha-1 receptor subunit (Charlton et al., 1997; Ortiz et al., 1995; 
Papadeas et al., 2001) located only on GABA, and not DA, VTA neurons (Tan et 
al., 2010). 
Ethanol-induced alterations in the neuronal stimulating profile of cocaine 
within the pVTA may also result in part from changes in local neuropeptide 
functioning. When released within the VTA, CRF and ORX peptides impart 
modulatory effects on drug-related behaviors through plasticity at NMDA 
receptors (Bonci and Borgland, 2009; Shalev et al., 2010; Wise and Morales, 
2010). Both CRF and ORX act within the VTA to increase DA neuronal firing and 
potentiate NMDA-excitation of DA neurons (Borgland et al., 2010). These actions 
ultimately increase DA release in terminal regions, such as the Acb. Intra-VTA 
injections of either ORX or CRF produce increases in local DA and glutamate 
levels and concomitantly trigger cocaine seeking (Wang et al., 2005, 2009). An 
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ethanol-induced up-regulation in type 1 and/or type 2 CRF receptor (CRF1, 
CRF2) functioning within the VTA could facilitate CRF potentiation of LTP, as 
chronic ethanol exposure produced increased expression of both receptor types 
and the CRF peptide in limbic brain regions (Heilig and Koob, 2007). Cocaine-
induced alterations in ORX transmission within VTA were associated with local 
synaptic plasticity, behavioral sensitization, and reinforcement (Aston-Jones et 
al., 2009, 2010; Borgland et al., 2006; Espana et al., 2010, 2011). Thus, ethanol-
induced increases in ORX afferent input to VTA DA neurons could reduce the 
threshold for cocaine activation of VTA DA neurons and/or promote cocaine-
induced plasticity. Injections of an ORX antagonist into the VTA attenuated cue- 
and stress-induced reinstatement of ethanol seeking (Richards et al. 2008). 
Chronic ethanol drinking by alcohol preferring rats increased the area of 
hypothalamic ORX mRNA expression (Lawrence et al., 2006).  
 Effects of Ethanol Experience Followed by Forced Abstinence 
 
Somewhat unexpectedly, P rats displayed an additional augmentation in 
the sensitivity of pVTA DA neurons to the stimulating actions of cocaine after 30 
d of abstinence from chronic ethanol drinking, relative to their ethanol-naïve and 
continuous-ethanol-access counterparts. Compared to the continuous drinking 
condition, an additional period of protracted abstinence produced: an increased 
maximal response of DA release at a low dose of cocaine; no significant change 
(instead of a robust increase) in DA levels at moderate dose; and similar pattern 
of dopaminergic inhibition at the highest dose of cocaine (Figures 16, 17, 19). 
Generally, the data represent a leftward shift in the dose-response curve (Figure 
20). Injections of 0.25 mM cocaine into the pVTA produced a robust increase in 
AcbSh DA levels (235% baseline), while injections of 0.5 or 2.0 mM cocaine 
produced no change or robust decreases in DA levels, respectively (60-80% 
baseline). The observation of a more robust increase in AcbSh DA after pVTA 
injections at the lowest concentration of cocaine examined (0.25 mM) in CE 
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versus N animals supports the interpretation of an increased sensitivity to 
cocaine’s DA-neuronal-stimulating effects after chronic ethanol drinking.  
Unfortunately, a reduction of threshold dose of cocaine needed to produce 
increased AcbSh DA levels was not confirmed, as 0.25 mM was the lowest 
concentration of cocaine examined. Additional experiments are warranted to 
examine the effects of protracted abstinence on the activation pVTA DA neurons 
by very low concentrations (0.05-0.10 mM) of locally applied cocaine. The 
concentration of 1.0 mM cocaine was not tested in the abstinent group of rats. 
However, given the pattern of dopaminergic inhibition at 1.0 mM in CE animals 
and at 2.0 mM in CE and Ab animals, a similar inhibitory response is likely. To 
this effect, concentrations of 1.0 and 2.0 mM cocaine potentially produced a 
maximal physiological level of pVTA DA neuronal inhibition (i.e. floor-effect). 
As with the previous experiment, accompanying data from an ICSA study 
examining the effects of protracted abstinence from chronic ethanol drinking on 
the self-administration of cocaine into the pVTA is not currently available. P rats 
trained for 6 wk to respond for 15% ethanol or water displayed increased lever 
responding for ethanol in either a FR or PR schedule after a 2- or 5-wk period of 
abstinence, suggesting an enhancement of reinforcer value during protracted 
abstinence (Rodd et al., 2003a). Furthermore, P rats receiving repeated cycles of 
ethanol (15% v/v) access and deprivation followed by a 7-wk period of 
abstinence displayed an increased sensitivity to the reinforcing effects of ethanol 
within the pVTA compared to both ethanol-naïve and continuous-ethanol-drinking 
animals (Rodd et al., 2005c). Along with the current experiments, this suggests P 
rats given 12 wk of access to 15% v/v ethanol followed by a 30-d period of 
abstinence would display an increased sensitivity to the reinforcing effects of 
cocaine within the AcbSh compared to both ethanol-naïve and continuous-
ethanol-drinking animals. Moreover, ethanol-abstinent P rats should also display 
higher levels of responding, compared to both ethanol-naïve and continuous-
ethanol-drinking animals, for the infusion of optimal concentrations of cocaine 
into the AcbSh during the reinstatement session. Future studies examining the 
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effects of abstinence duration and ethanol re-exposure cycles on the reinforcing 
and DA-neuronal-stimulating effects of cocaine within the AcbSh and pVTA could 
significantly contribute to understanding the how the observed neurochemical 
effects of cocaine in the mesolimbic DA system are associated with the 
acquisition of reinforced behavior. 
The enhancement of sensitivity of the pVTA to the DA neuronal effects of 
cocaine observed after abstinence from ethanol drinking likely reflects a further 
progression of neuroadaptive processes occurring during and after withdrawal 
from ethanol (Koob and Volkow, 2010). These progressive adaptations are 
manifest as an enhanced dysregulation of basal neurotransmission, receptors, 
neuromodulator function, and intracellular processes. Increased basal DA levels 
in the Acb of P rats persisted for at least a 2-wk period after termination of 
ethanol drinking (Thielen et al., 2004). Ethanol-induced changes in D1 binding in 
the Acb was observed as far as seven months after the conclusion of ethanol 
treatment (May, 1992), while alterations in VTA DA neuronal firing persisted 
through at least a 6-wk period of abstinence (Shen et al., 2007).   
Potential mechanisms for the effects observed in the current experiment 
involve the enhancement of CRF and ORX functioning during protracted 
abstinence. A significant role for CRF’s actions within the VTA to mediate drug 
seeking and relapse at time points far into protracted abstinence has been well 
characterized (see Sarnyai et al., 2001; Shalev et al., 2010). Wistar rats with 2 
wk of voluntary ethanol drinking followed by 20 d of abstinence showed a 
relatively selective increase in hypothalamic expression of CRF1, CRF2, and ORX 
receptor type 1 genes (Pickering et al., 2007). Chronic ethanol drinking produced 
a transient decrease in CRF levels within the amygdala of Wistar rats, with levels 
returning to normal after 3 wk (Zorrilla et al., 2001). Interestingly, CRF levels 
were significantly higher in ethanol-exposed animals after a 6-wk period of 
protracted abstinence, compared to ethanol-naïve controls. Thus, gradual 
increases in VTA CRF functioning occurring after acute ethanol withdrawal and 
during protracted abstinence could provide the enhanced ability of cocaine to 
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activate VTA DA neurons. Abstinence could also produce the observed effects 
via an enhancement in ORX excitatory tone to DA neurons in the pVTA. Inbred P 
rats displayed an increased Fos expression in a number of brain regions during 
the immediate cue-induced reinstatement from oral ethanol reinforcement, while 
pretreatment with a ORX antagonist eliminated reinstatement responding and 
blunted Fos expression (Jupp et al., 2011). Moreover, delaying reinstatement for 
five months potentiated the Fos response compared to immediate reinstatement, 
and ORX antagonism retained the ability to eliminated reinstatement and 
attenuate Fos expression.  
Overall, the results confirm the pVTA as an important brain region 
mediating the neurochemical effects of cocaine-evoked increases DA levels in 
mesocorticolimbic terminal regions, such as the AcbSh. The results also support 
the hypothesis that a prolonged period of ethanol drinking increases the 
sensitivity of the pVTA to the DA-neuronal-stimulating effects of cocaine. The 
inhibition of pVTA neurons in ethanol-naïve animals after injections of 
concentrations greater than 2.0 mM cocaine would suggest ethanol-drinking 
experience produced a global shift in the local actions of cocaine within the pVTA 
(i.e. increased sensitivity to the stimulating and inhibitory effects of pVTA 
cocaine). Furthermore, a period of protracted abstinence enhanced the effects of 
ethanol drinking, in contrast to the hypothesis that the effects of continuous 
ethanol drinking on the DA-neuronal-stimulating actions of intra-pVTA cocaine 
would endure for 30 d. For abstinent animals, the confirming pVTA injections of 
cocaine concentrations less than 0.25 mM elicit significant increases in AcbSh 
DA not seen in continuous ethanol drinking rats (i.e. observation of a leftward 
shift of the dose-response curve) will increase support for the current findings. In 
summary, the results point to the occurrence of ongoing changes in neuronal 
functioning beyond acute withdrawal from chronic ethanol drinking and into 
periods of protracted abstinence. 
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 Integrated Discussion 
 
Adult P rats will voluntarily consume significant amounts of ethanol if given 
continuous free-choice access, and this ethanol-drinking experience increased 
the sensitivity to the local reinforcing and stimulatory effects of cocaine within the 
mesoaccumbens DA circuit. The consequences of continuous ethanol-drinking 
experience were manifest as alterations to the behavioral and neurochemical 
profile of the central actions of cocaine within brain regions containing 
mesocorticolimbic DA cell bodies (pVTA) or terminals (AcbSh).  
Confirmation of similar ethanol-induced alterations in the complementary 
behavioral or neurochemical dose-response to cocaine within the same brain loci 
will increase support for the current findings. In the AcbSh, data was obtained for 
the behavioral response to local self-infusion to cocaine, but an assessment of 
the associated neurochemical changes is warranted. This is accomplished by the 
concurrent local application of cocaine via perfusion into the AcbSh (i.e. reverse-
microdialysis) and collection of brain dialysates for DA measurement through a 
single in vivo microdialysis probe (for description, see Andrews and Lucki, 2001; 
Engleman et al., 2003). Additional experiments using quantitative methods can 
obtain information correlated with DA uptake (for description, see Chefer and 
Shippenberg, 2002; Yim and Gonzales, 2000). In the pVTA, data was obtained 
for the ‘down-stream’ neurochemical response to experimenter-administered 
cocaine, but an assessment of the associated behavioral changes is not 
complete. Dose-response experiments examining self-infusion of cocaine into the 
pVTA are crucial for a comprehensive interpretation of the effects of chronic 
continuous ethanol drinking and subsequent ethanol abstinence on the 
reinforcing and DA-neuronal-stimulating effects within the pVTA.  
In agreement with other ICSA, intracranial place conditioning, and 
microinjection-microdialysis studies examining the neurocircuitry of drugs of 
abuse, the effects of cocaine were localized within the pVTA, as opposed to the 
aVTA or adjacent midbrain regions. Also of interest is the site-specific nature and 
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administration contingency of ethanol-induced alterations in the central 
reinforcing and DA-neuronal-stimulating effects of cocaine. For example, 
repeated daily ethanol or nicotine pretreatment injections directly into the pVTA 
were sufficient to induce a neurochemical sensitization to the DA-neuronal-
stimulating effects of ethanol (Ding et al., 2009a, 2011). In this case, the drug 
pre-exposure was both site-specific and non-contingent. Experiments examining 
the relative magnitude and time course of such effects will be useful to 
characterize the specific influence of these variables. For example, does local 
pretreatment of the pVTA with repeated microinjections of ethanol enhance the 
subsequent ICSA of cocaine into the pVTA, and do these effects persist to the 
same degree as an effect induced by voluntary ethanol drinking? Lastly, 
experiments examining the effects of the pattern and time course of drinking 
behavior and abstinence periods will also provide additional insight into the 
development of ethanol-induced neuronal adaptations associated with the 
enhancement of the reinforcing effects of cocaine within the MVM DA circuit. For 
example, limited access schedules of alcohol availability, repeated cycles of 
ethanol access and abstinence, and periods of protracted abstinence beyond 30 
d would mimic the human behaviors associated with binge drinking and relapse. 
 Conclusions 
 
In summary, chronic continuous voluntary ethanol drinking by female P 
rats enhanced both the reinforcing effects of cocaine within the AcbSh and the 
stimulatory and inhibitory effects of cocaine on pVTA DA neurons. Alterations in 
the stimulatory and inhibitory effects of cocaine on pVTA DA neurons were not 
only enduring, but also enhanced, following a period of protracted abstinence 
from ethanol exposure. Thus, voluntary ethanol-drinking experience, by animals 
with a genetic predisposition for high ethanol intake, altered the site-specific 
actions of cocaine within the mesolimbic regions of the CNS. In human 
populations, moderate to high levels of alcohol drinking potentially produces 
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neuroplastic alterations within the brain mediating an increased susceptibility to 
the positive reinforcing effects of cocaine often observed during early drug 
experiences. Functional alterations in MVM DA circuits during the acquisition of 
cocaine self-administration suggest a potential increased vulnerability may be 
associated with the earlier stages of compulsive drug taking behaviors. 
Therefore, prevention of chronic and excessive alcohol intake in populations with 
a genetic predisposition for substance abuse could reduce the proclivity to 
develop maladaptive patterns of cocaine use. It is unknown, however, if the 
observed effects are specific to animals with a genetic preference for ethanol. 
Also uncertain is whether other putative ‘gateway’ drugs, such as nicotine and 
marijuana, share ethanol’s mechanisms of action or produce neuronal alterations 
though distinct substrates. For example, repeated nicotine exposure enhanced 
cocaine-evoked synaptic plasticity, behavioral sensitization, and reinforcement 
via increased histone acetylation (Levine et al., 2011), a post-translational 
adaptation also observed after chronic ethanol exposure (McBride et al., 2009; 
Pascual et al., 2009). Thus, treatments targeting common putative substrates 
and addressing both direct drug effects and the sequential progression of 
polydrug use may be more effective at preventing drug and alcohol misuse than 
individual treatments. 
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